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PREFACE 
This report presents findings from a national evaluation of 14 
drug court programs that received funding by the Drug Courts Program 
Office in 1995 and 1996.  The evaluation  was funded by the National 
Institute of Justice with funds transferred from the Drug Courts Program 
Office.  This study was designed to develop a framework for drug courts, 
document program implementation,  and assess the "evaluability"  of the 14 
programs for future eva1uation.l  In this report,  we argue that drug 
court research currently has no unifying perspective regarding the 
structural and process characteristics of drug courts that can be used 
to link drug court components with outcomes.  We develop a testable 
framework that should allow researchers to do this.  Our findings on 
implementation  are based on interviews and observations conducted during 
site visits to each jurisdiction,  as well as program materials, existing 
evaluations,  and management information systems. In addition,  we present 
findings on the overall "evaluability"  of the programs for rigorous 
process and outcome evaluations. 
The report should be of interest to practitioners and evaluators 
interested in sentencing options for drug-involved offenders,  as well as 
those interested more specifically in drug courts. 
Other RAND  research on drug courts includes: 
Douglas Longshore,  Susan Turner, Suzanne L Wenzel, Andrew Morral, 
Adelle Harrell, Duane McBride, Elizabeth Piper Deschenes,  and Martin 
Iguchi  (2001).  "Drug  Courts: A Conceptual Framework,"  Journal of  Drug 
Issues,  Vol. 31,  pp-  7-26. 
Additionally, the project was to propose a Phase I1 evaluation 
plan for each of the 14 sites.  Our determination was that most sites 
could support only limited process and outcomes studies, and that an 
alternate methodology be employed.  Details of this approach can be 
obtained from the authors. 
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SUMMARY 
BACKGROUND 
Drug courts have become one of the fastest growing criminal 
justice innovations  aimed at crlme reduction.  The first drug courts 
were established in the late 1980s.  As  of June 2000.  over 500 courts 
had become operational  (Belenko  2000).  Judicial interest is 
"particularly  strong because drug courts place much of the case 
management control back into the hands of judges--a  function that has 
eroded over the years.  Drug courts also hold promise as a means to 
reduce drug use and related criminal behavior of drug-involved 
defendants by delivering drug treatment and close judicial monitoring.2 
The Drug Courts Program Office (DCPO)  provides funding to drug 
courts for planning, implementation,  and enhancement of local drug 
courts.  In 1995 and 1996,  14 programs received DCPO implementation 
grant funding.  These sites were asked to cooperate with a national 
evaluation funded by the National Institute of Justice (NIJ).  This 
report presents findings on 
program implementation of the drug courts 
a conceptual framework of the 14 drug courts funded by DCPO 
program evaluability for  participating jurisdictions3 
Early drug courts focused on expediting case calendars.  We do 
not consider these here. 
Additionally, the project was to propose a Phase I1 evaluation 
plan for each of the 14 sites.  Our determination was that most sites 
could support only limited process and outcomes studies,  and that an 
alternate methodology be employed.  Details of this approach can be 
obtained from the authors. 
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STUDY METHODOLOGY 
Site visits were conducted at each of the selected 14 
jurisdictions that received DCPO funding in 1995 and 1996.  Site 
visitors were requested to: 
conduct interviews  with the drug court coordinator, drug 
court judge,  probation, defense and district attorneys, and 
major substance abuse providers 
attend drug court hearings and status reports (and  staffing 
meeting if possible) 
visit major substance abuse treatment program(s1 and obtain 
a list of all service providers 
examine case file record keeping 
obtain copies of assessment/eligibility  paper forms, 
progress reports, etc., for drug court participants 
obtain layout for computer MIS files that contain background 
and program process data 
obtain information on routine criminal justice record 
keeping  (arrests,  court processing,  probation files) 
obtain copies of existing process/outcome evaluations 
completed by the site 
Based on information gathered from these activities, site visitors 
completed for each site a "Drug  Court Evaluation Site Visit Protocol.' 
This protocol was developed in order to capture similar information 
across all 14 sites.  A  series of individual questions in major domains 
relating to program model; general program characteristics;  client flow, 
eligibility, and characteristics;  staffing;  environment/context;  funding 
and costs;  pro-iision  of treatment and other services;  reinforcements, 
punishments, rewards,  and sanctions; intensity; rehabilitative versus 
surveillance  philosophy; monitoring and supervision;  linkage and 
collaboration;  administrative leadership and cooperation;  program 
implementation;  implementation barriers; and "evaluability"  were 
completed for each program. 
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STUDY FINDINGS 
Program Implementation 
Our analysis of program implementation--the  types of models 
implemented,  eligibility requirements,  court and treatment requirements, 
and program implementation  difficulties--reads surprising like findings 
from the surveys conducted by American University and National TASC. 
These 14 programs are in many ways typical of drug court programs across 
the county.  I 
To a large degree, the 14 programs meet many of the key components 
of effective drug court programs.  Drug courts integrate alcohol and 
other drug treatment services  with justice system case processing; they 
use a non-adversarial approach; prosecution and defense counsel promote 
public safety while protecting due process rights of participants; 
eligible offenders are identified early; drug courts provide access to a 
continuum of alcohol, drug, and other treatment related services; 
abstinence is monitored by frequent testing; a coordinated strategy 
governs drug court responses to participants' compliance;  and ongoing 
judicial interaction  with each participant is maintained.  It appeared 
that the most difficult component to meet was the monitoring and 
evaluation for the achievement of program goals and effectiveness.  In 
the 14 sites  we examined, this clearly was not implemented to the degree 
of other key elements. 
However, even with the other nine key elements, the 14 sites 
experienced success in varying degrees.  Access to a continuum of 
alcohol and drug services and other related rehabilitative services was 
often difficult,  reflecting funding issues, as well as close 
coordination and information flow issues between treatment providers and 
other drug court staff.  Although drug courts may specify protocols and 
graduated sanctions for non-compliance, in some instances a more 
individually tailored response is used. 
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Conceptual  Framework 
Our framework was developed to define structure and process in 
ways that are measurable and amenable to hypothesis testing.  The 
framework has five\dimensions:  leverage, population severity, intensity, 
predictability, and rehabilitation emphasis.  The first two dimensions 
are structural characteristics of drug court.  Leverage refers to the 
nature of consequences faced by incoming participants if they later fail 
to meet program requirements and are discharged from drug court. 
Population severity refers to characteristics of offenders deemed 
eligible to enter drug court.  The other three dimensions are process 
characteristics.  They describe what happens to participants as they 
proceed through the drug court program.  Intensity refers to 
requirements for participating in and completing drug court.'  These 
always include urine testing, court appearances,  and drug abuse 
treatment.  Predictability reflects the degree to which participants 
know how the court will respond if they are compliant or noncompliant. 
Courts with less variability in responses to each positive test are more 
predictable; participants are more likely to know what will probably 
happen to them if they test positive once, twice, and so on. The final 
dimension in our framework is the emphasis placed on rehabilitation  as 
against other court functions, including case processing and punishment. 
Other things being equal, we would expect more positive drug court 
outcomes for drug courts that rank high on indicators of intensity, 
predictability,  rehabilitation,  and leverage.  The effect of population 
severity on outcomes most likely depends upon other dimensions of the 
framework; thus we made no simple hypotheses for this component.  We 
provide examples of these dimensions  using the 14 drug courts.  Our 
asses  smen 
to gather 
dimension 
be useful 
of the courts is tentative,  however, since we were not able 
the data we suggest is needed to fully  document each 
However.our analysis shows variation across sites that might 
for future analyses of program outcomes. 
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"Evaluability" of the 14 Drug Court  Programs 
Our analysis of the "evaluability"  of each of the 14 sites  was 
based upon information gathered from site visits made to each program by 
study staff that included program documents and manuals; interviews  with 
Drug Court staff, judges,  prosecutors,  defense attorneys, and,  treatment 
providers; examination of paper and computerized records; and 
observation of drug court proceedings.  In general,  we found that the 
strongest design for most sites,  given their current data collection 
,activities,  would be quasi-experimental  and limited to administrative 
data, and would require a fair amount of on-site  abstraction.  Many 
sites did not routinely collect the data items recommended by the DCPO. 
The greatest stumbling blocks to traditional evaluation were the 
lack of integrated management information system and adequate comparison 
groups.  In addition,  self-reported information on offender  and system 
actor perceptions,  necessary for understanding the "black  box" of drug 
court treatment,  were not'collected  by sites. 
Taking Drug Court Research A  Step Further 
Drug court research is at a crossroads.  Available information to 
date suggests that programs deliver more intensive services  with 
positive outcomes for recidivism and drug use, at least in the short 
term.  However, many of these results come from weak evaluation designs. 
Conducting additional weak evaluations may add little to our knowledge. 
Recently, researchers and observers in the field have been calling for 
more sophisticated research into testing the theory behind how drug 
courts achieve their results (Harrell  1999), evaluating the treatment 
component using principals of effective intervention (Johnson,  Hubbard, 
and Latessa 2000).  untangling the drug court "package"  to determine 
which components  make a difference (Belenko  2000,  Marlowe and Festinger 
2000;  Goldkamp,  White, and Robinson 2000),  and conducting cost-benefit 
analyses in a rigorous manner (California  Judicial Council 2000).  For 
example,  the National Institute on Drug Abuse has recently funded a set 
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of program evaluations to answer questions about specific components of 
drug court programs.  Projects currently underway include a clinical 
trial of Multi Systemic Therapy for juveniles,  the use of vouchers in 
drug courts,  and a randomized design that varies the nature of judicial 
hearings in five jurisdictions.  Johnson, Hubbard, and Latessa (2000) 
argue that many treatment programs utilized by drug court programs may 
\ 
not be delivering the best treatment to clients.  They suggest more 
attention be paid to the type and quality of treatment services, 
including the application of the principles of effective intervention.  I 
Central to any future evaluations, however, is the development at 
each site of a management information system (MIS)  that captures the 
required background,  process, and outcome measures important to all 
research designs.  Our study of the 14 drug court programs revealed that 
many did not have an MIS in place, despite the availability of several 
(e.g.,  Jacksonville and Buffalo Drug Court MIS, Washington/Baltimore 
High Intensity Drug Trafficking Area  (HIDTA)  Treatment Tracking System). 
It may be that the availabie systems do not provide full-service  drug 
court management information capability (Mahoney  et al. 19981,  or the 
difficulties involved in establishing systems (e.g.,  costs, coordinating 
agencies)  may be too great for many jurisdictions,  particularly smaller 
ones. 
In addition to providing useful information on process and outcome 
measures, comprehensive MISS have implications for the timeliness of 
client information-sharing  and thus for clients' access to services. 
Linkages can be more readily made, and referrals  more prompt and 
appropriate, if the drug court's MIS includes data on a full array of 
client needs and if the assessment tools are suitably rigorous. 
The importance of drug court evaluation cannot be overstated.  The 
drug court model has been adopted in a variety of other areas, including 
mental health, domestic violence, and DUI sentencing.  It is imperative 
that we gain a better understanding of  overall impact, theoretical 
underpinnings, and key components if the drug court model is to be 
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widely disseminated as a successful approach for treating a variety of 
criminal behaviors and associated illnesses. 
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I.  INTRODUCTION 
DRUG COURT MOVEMENT 
Drug courts have become one of the fastest growing criminal  , 
justice innovatiohs aimed at crime reduction.  The first drug courts 
were established in the late 1980s.  As of June 2000,  over 500 courts 
had become operational (Belenko  2000).  Judicial interest is 
particularly strong because drug courts place much of the case 
management control back into the hands of judges--a  function that has 
eroded over the years.  Drug courts also hold promise as a means to 
reduce drug use and related criminal behavior of drug-involved ' 
defendants by delivering drug treatment and close judicial monitoring.4 
Title V of  the Violent Crime Control and Law Enforcement Act of 
1994 authorized awards of federal grants for drug courts.  Since 1995, 
with funding from the Office of Justice Programs (OJP),  awards have 
been granted for implementation  of new and enhancement of existing drug 
courts, as well as for planning grants.  Under this initiative,  drug 
courts have been developed at the local level in accordance  with OJP 
requirements, including early and continuing judicial supervision; 
mandatory periodic drug testing; substance abuse treatment and other 
rehabilitative services; integrated administration of services and 
sanctions; the exclusion of violent offenders from participation; and 
the possibility of prosecution, confinement, or incarceration for 
noncompliance or lack of  satisfactory progress. (American  University, 
http://www.american.edu/iustice,  2000a), 
Early drug courts focused on expediting case calendars.  We do 
not consider these here. 
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The Drug Courts Program Office (DCPO)  provides funding to drug 
courts for planning, implementation, and enhancement of local drug 
courts.  In 1995 and 1996, 14 programs received DCPO implementation 
grant funding.  These sites  were asked to cooperate with a national 
evaluation funded  by the National Institute of Justice (NIJ).,  This 
report presents findings on 
program implementation  of the drug courts 
a conceptual framework of the 14 drug courts funded by DCPO 
program evaluability for participating jurisdictions5 
In Chapter I1 we discuss the drug court model and briefly review 
the literature on the implementation and effectiveness of drug courts. 
In Chapter I11 we discuss the 14 participating sites and their 
requirements under their DCPO grants.  Chapter IV presents the study 
methodology.  Chapter V cqntains the analysis of program 
implementation. In Chapter VI we present the framework for drug courts 
that we developed; in Chapter VI1 we discuss the evaluability of the 14 
programs.  Chapter VI11 presents the summary and conclusions. 
Additionally,  the project was to propose a Phase I1 evaluation 
plan for each of  the 14 sites.  Our determination was that most sites 
could support only limited process and outcomes studies,  and that an 
alternate methodology be employed.  Details of this approach can be 
obtained from the authors. 
This document is a research report submitted to the U.S. Department of Justice. This report has
not been published by the Department. Opinions or points of view expressed are those of the
author(s) and do not necessarily reflect the official position or policies of the U.S. Department of
Justice.-3- 
11.  DRUG COURTS AND THEIR EFFECTIVENESS 
WHAT IS A  DRUG COURT? 
Drug courts emerged in 1989 as a distinctly different way of 
dealing with drug offenders.  In contrast to a more traditional punitive 
court processing, drug courts use active and intensive judicial 
supervision coupled with drug treatment and sanctions in a more 
,therapeutic  environment (see  Goldkamp 1994,  1999,  2000;  Hora, Schma, and 
Rosenthal 1999).  In exchange for successful completion of a drug court 
program, offenders are rewarded--with  dismissed charges, or reductions 
in sentence--as  determined by the drug court program. 
Effective drug court programs are based qn an understanding of the 
physiological,  psychological,  and behavioral realities of drug abuse and 
are implemented with those realities in mind.  This results in a much 
less adversarial approach’than in traditional courts.  Emphasis is on 
immediate intervention;  coordinated,  comprehensive supervision; long- 
term treatment and aftercare;  and progressive sanctions and incentive 
programs  (Inciardi  et al. 1996).  An  effort is made to keep even non- 
compliant offenders in the program, using both encouragement and 
graduated sanctions.  Through the combination of drug treatment and 
sanctions,  drug courts hold promise as an effective mechanism to break 
the cycle of substance abuse and crime. 
No specific set of characteristics defines a drug court program. 
However,  compared with traditional dockets,  drug courts offenders appear 
more frequently in front of judges; are required to enter into an 
intensive outpatient program that usually entails at least three 
sessions per week with a treatment professional;  undergo frequent. 
random urinalysis;  undergo sanctions for failure to comply with program 
requirements; and are encourage to become drug free,  develop vocational 
and other skills to promote reentry into the community (American 
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a 
--4. 
University, htt~:/iwww.american.edu!iustice/nacofct.htm,  September 22, 
2000). 
In an effort to provide guidance for drug court development and 
operation,  the Drug Courts Program Office (DCPO),  in collaboration  with 
drug court experts and practitioners,  has developed a set of key 
components that are seen as a flexible framework and also lay the 
foundation for evaluation research (Drug  Courts Program Office 1997)6. 
These components include: 
Drug courts integrate alcohol and other drug treatment 
services  with justice system case processing. 
Using a non-adversarial  approach,  prosecution and defense 
counsel promote public safety  while protecting participants' 
due process rights. 
Eligible participants are identified early and promptly 
placed in the drug court program. 
Drug courts provide access to a continuum of alcohol, drug, 
and other related treatment and rehabilitation services. 
Abstinence is monitored by frequent  alcohol and drug 
testing. 
A  coordinated strategy governs drug court responses to 
participants' compliance. 
Ongoing judicial interaction with each drug court 
participant is essential. 
The discussion and development of key elements of drug courts has 
been ongoing for some time.  Goldkamp (1994)  outlines nine core elements 
that developed out of the First National Drug Court Conference in 
December 1993.  They include: judicial leadership and central judicial 
role; collaboration beyond the norm with criminal justice agencies, 
courts, treatrrznt agencies,  and community organizations;  inclusion of 
effective education and cross training for criminal justice and 
treatment agencies and staff;  a custom-designed  treatment program for 
targeted offenders; a treatment court that addresses a specifically 
defined target population; an integrated management information system; 
identification of stable funding sources;  overall detailed 
implementation plan for the drug court program for all involved parties, 
roles,  and timetable;  and an evaluation strategy,  designed at the 
outset, that defines outcomes of interest, information needed,  and 
timetable for analyses and reporting (Goldkamp  1994,  p- iii). 
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Monitoring and evaluation measure the achievement of program 
goals and gauge effectiveness. 
Continuing interdisciplinary education promotes effective 
drug court planning, implementation,  and operations. 
Forging partnerships among drug courts, public agencies, and 
community-based organizations generates local support and 
enhances drug court 'program  effectiveness (Drug  Courts 
Program Office 1997). 
How do drug courts actually operate?  Surveys on drug courts and 
their characteristics  have been ongoing by the American University aver 
the past several years.  Recent national survey data on drug court 
programs published by American University summarizes characteristics 
and implementation  experiences of 93  courts in early 1997  (American 
University 1997).  The survey results reveal that even though drug 
court programs define their own  offender  eligibility criteria,  most 
courts exclude violent offenders, those who have violated parole, and 
those with out-of-county  residence.7  Programs differ as to the extent 
of  the offender's prior record.  Over half of the surveyed programs in 
1997 allowed offenders  with any number of prior offenses,  provided they 
met other eligibility criteria.  Although programs accept offenders 
with varying degrees of  substance use problems,  almost 90 percent 
target offenders with severe use.  Approximately 40 percent of programs 
have modified their eligibility criteria over time,  many to relax 
criminal history and offense requirements;  others have tightened 
criteria to reduce the number eligible (Cooper  1997). 
Most of the programs require weekly or bi-weekly contact with the 
judge during the early phases of the program.  Defense attorneys and 
Programs funded by  DCPO specifically exclude violent offenders. 
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prosecutors often attend status hearings.  Most programs require at 
least three contacts a week (often  more) with the treatment provider, 
along with at least weekly urinalysis testing, for the early phases of 
the program.  A system of graduated sanctions,  such as short-term 
incarceration and use of alternatives including electronic monitoring, 
is used to respond to positive drug tests or failures to attend 
treatment.  Sixty percent of surveyed drug courts order incarceration 
for up to three days as a judicial response to relapse and/or non- 
compliance, although 80 percent also increase the frequency and/or 
I,. , 
intensity of treatment services.  Although most courts do not terminate 
an offender simply for arrest on a new drug charge,  many will terminate 
cases with arrests for drug trafficking.  To graduate from the program, 
offenders are required to complete treatment  (in  almost 70 percent of 
programs, treatment durat4on was at least one year) and, in some 
jurisdictions,  must remain drug free for a specified period of time. 
The most frequently cited reason for unsuccessful termination from 
programs (outside  of  new arrests) is repeated positive urine tests, 
chronic failure to attend treatment,  and repeated failure to attend 
court hearings (Cooper  1997). 
Drug courts have different experiences in their implementation, 
and many have had to overcome initial hurdles in their establishment. 
Many jurisdictions report a lack of adequate funding for drug court 
programs (over  one-third  receive local funding; one-third,  Byrne 
funding;  one-quarter,  federal funds).  Some courts mention difficulties 
identifying clients and making referrals to treatment.  Others report 
problems with the availability and quality of treatment services (about 
one-quarter report managed care limitations on the nature an2  extent of 
treatment services available) and difficulties  in coordinating 
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also causes difficulties for several courts (Cooper  1995, 1997). 
A  recent survey conducted by National TASC, in cooperation with 
the Drug Courts Program Office and the Center for Substance Abuse 
Treatment, surveyed over 250 drug court programs in late 1999.  The 
survey focused on'the  types of services available to drug court clients 
and the ways in which clients are processed into these services (TASC 
2000).  The majority of programs reported that they include adjudicated 
offenders, either exclusively or in addition to lower-level  offenders  I 
diverted from prosecution.  Adult drug court participants include felony 
and misdemeanor offenders, offenders  with drug charges, drug-related 
offenses, and probation violations.  Consistent with the American 
University findings  mentioned above, most exclude violent offenders from 
their target offense groups. 
Most drug courts were fairly small.  Twenty-,seven  percent have 
fewer than 50 participants in their programs, 42 percent have between 
50 and 150 participants, and 31  percent have more than 150 
participants.  Drug courts try to provide a range of services for 
offenders and monitor these with drug and alcohol testing and 
sanctions/interventions  designed to promote compliance.  Most drug 
courts require participants to remain in treatment for a year,  with 
treatment generally consisting of group and individual counseling. 
TASC found that overall,  drug court programs structure and deliver 
treatment in line with established principles.  However, several issues 
remain.  Assessment and screening may not be performed by appropriate 
staff using accepted clinical tools; management information systems are 
often not comprehensive or tied into larger justice or treatment data 
systems;  and many rely on relatively informal relationships  with the 
providers they use, making them vulnerable to changes in financing and 
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policies that occur in the mainstream treatment and mental health 
environment  (TASC  2000,  p. 4). 
DRUG COURT EFFECTIYNESS 
The impact of drug courts on the criminal justice system has been 
varied.  Some coufts report a reduction in judicial dockets,  probation 
caseloads,  and jail bed days; savings in police overtime; and general 
savings in system costs.  Many report reductions in offender drug use 
during program participation.  The most comprehensive reviews of the 
findings from drug court evaluations have been conducted by Belenko 
(1998,  1999). 
updated review of almost 60 evaluations of 48 different courts, a 
In his initial review of 29 drug court evaluations and 
number of findings have emerged: 
Drug courts arg treating more complex  'offenders  than 
previously known.  Offenders have more serious criminal 
histories, previous exposure to treatment without success, 
and complex physical and mental health needs. 
Drug court participants' drug use while in programs remains 
low compared to similar offenders not in drug court. 
Drug court participants' retention and graduation rates 
remain high compared with other outpatient treatment 
programs. 
For those drug court participants who eventually graduate, 
re-arrest rates are low during the drug court program. 
Drug court participants experience lower post program 
recidivism rates than comparison groups. 
Drug court programs generate cost savings primarily to law 
enforcement,  probation and jail (Belenko  1999,  p.2). 
Despite the growing evidence on the implementation and 
effectiveness of drug courts, drug court research continues to have its 
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limitations.  Process evaluations dominate the field,  partly due to the 
DCPO requirement that funded sites complete a process evaluation of 
their programs.  Methodological problems limit many outcome studies. 
Weak or non-existent comparison groups, short follow-up  periods, and 
limited outcome measures focused on available of  ficially-recorded 
recidivism outcomes and urinalysis tests (as  opposed to psycho-social 
measures of  family reintegration, job skills attainment,  actual drug 
use, etc.) are typical.  Beyond methodological problems, however, are 
more theoretical concerns about the "theory"  behind drug courts and our 
understanding of the "black  box" of treatment  (see  Harrell 1999;  Taxman 
\ 
1999).  Research needs to delve deeper into understanding key 
conceptual ingredients necessary for drug court success (Belenko  2000). 
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111.  THE 14 PARTICIPATING SITES 
Fourteen drug courts in ten states and territories received 
implementation funding from the Drug Courts Program Office (DCPO)  in 
1995 and 1996.  These programs are the focus of the current study.  The 
participating drug programs are listed in Table 3.1 below. 
Table  3.1 
The 14 Drug Courts Studied 
Region  State  Award  Year 
Birmingham  A1  abama  1996 
Tuscaloosa  A1  abama  1995 
Sa  cramen  t  o  California  1995 
Santa Barbara  California  1995 
Riverside  California  1996 
Tampa  F1  or  ida  1996 
At  1  anta  Georgia  1996 
Chicago  Illinois  1995 
Kankakee  I11  inois  1996 
Omaha  Nebraska  1996 
Brooklyn  New York  1995 
San Juan  Puerto Rico  1996 
Roanoke  Virginia  1996 
Spokane  Washington  1996 
DCPO provided implementation grants to these jurisdictions for 
drug courts that operate a specially designed court calendar or docket 
for the purposes of: 
reducing recidivism and substance abuse among non-violent 
adult and juvenile substance abusing offenders 
increasing the likelihood of  their successful rehabilitation 
through early, continuous,  and judicially supervised 
treatment;  mandatory periodic drug testing; the use of 
graduated sanctions; and other rehabilitation services (NIJ 
1998) 
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Requirements by Sites to Collect Process Information and Participate in 
a National Evaluation 
Drug courts receiving funding by DCPO are required to collect 
program and process information from all drug court components, to the 
fullest extent possible.  The DCPO requested that courts (ideally) 
provide  :  \ 
identification of the screening criteria used to determine 
eligibility and acceptance into the drug court program 
(including  the type of offenses allowed) 
identification of the point in the criminal justice process 
where the program intervenes (e.g.,  pretrial, post- 
conviction) 
description of the potential population eligible €or the 
drug court program (including  demographic information about 
the surrounding community and the numbers and 
characteristics of clients served) 
description of intake and assessment procedures and 
screening instruments 
detailed description of  the type of program established, its 
distinguishing characteristics,  and services provided 
(including administrative and budgetary elements,  personnel 
and their allocation to specific tasks, average length of 
participation in the drug court overall, and supervision 
provided to participants),  especially type and phase of 
treatment and other interventions provided (e.g., 
therapeutic community or initial detoxification phase) 
identification  of how the system responds to relapses,  what 
interventions  are used, and what incentives are offered for 
progress 
identification of case management and monitoring procedures 
to ensure that each defendant is closely monitored 
description of the drug court caseload's impact on the rest 
of the court system 
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description of the discharge and referral procedures used 
when a participant completes the program (or  fails to 
complete the program) 
description of the role of the judge,  prosecutor, and 
defense attorney and how their roles in the drug court 
program vary from their roles in other courts in the system, 
as well as the type of coordination and cooperation required 
with other linkages in the system (e.g., pretrial services, 
probation,  parole, treatment providers and other support 
service providers, and community agencies) 
description of what information  will be routinely available 
to the judges and other program participants 
identification  of any public policy issues that 
significantly affect the drug court program 
The following items were to be collected for drug court 
participants and, to the extent possible, non-participants 
(ineligibles,  refusals,  and those processed before drug court was 
created): demographic characteristics,  substance abuse history and 
current levels of use, family relationships and social functioning, 
vocational status,  economic status, academic achievement,  mental health 
history (including history of physical or sexual abuse),  medical 
history (including  HIV risk behaviors), criminal justice history, 
attitudes toward treatment motivation or readiness for treatment, 
initial treatment and support service  needs,  program interventions 
received (including  length and type),  participation in treatment 
(including  motivation and actual attendance records for each program 
component),  date of  program admission and discharge, status at 
completion of drug court program (e.g.,  successful),  criminal justice 
status at discharge (e.g.,  probation), service needs at discharge from 
program (e.g.,  job placement), and discharge referrals initiated by the 
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drug court (Drug  Courts Program Office 1996,  p. 29-31).  To gather this 
information,  participating sites were encouraged to design, implement, 
and maintain an automated data collection system. 
In addition to the information mentioned above, the DCPO 
solicitation stressed that the drug court programs should anticipate 
providing the following types of information,for  an impact evaluation: 
substance abuse treatment and support services completion rates; 
counselor ratings of the extent of participant attendance, engagement 
in treatment program components,  and improvement over time in life 
skills acquisition,  psychological and emotional functioning,  cognitive 
t 
functioning,  and educational and employment status; incident or,  ' 
disciplinary reports during program involvement;  participant 
,,  ,I 
satisfaction  with the treatment program; reports of substance abuse; 
results of urinalysis tests;  probation/parole status and change in 
status;  date and type of  each charge, arrest, technical violation, 
conviction, and incarceration during program participation and during 
aftercare (including  offense severity,  differentiation between old and 
new charges, and conviction or sentence status for each arrest); 
positive social adjustment indicators (e.g.,  participation in team 
sports,  volunteer work, improved employment status);  and counselor 
ratings of the extent of participant attendance and engagement in 
aftercare  components and referral services following completion of the 
drug court program (Drug  Courts Program Office 1996,  p. 33). 
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IV.  STUDY  METHODOLOGY 
The major source of information for the present study was 
collected during site visits at each of  the selected 14 jurisdictions 
that received DCPO funding in 1995 and 1996.  The purpose of the visits 
was to gather information related to the drug court program model and 
implementation  experiences, the target population characteristics, 
jurisdictional context,  drug court participant experiences and outcomes, 
and ongoing data collection efforts and evaluation. 
evaluation and site visits were introduced  by a letter from Marilyn 
Roberts, Director of the Drug Courts Program Office, to each 
participating program; individual  project staff then followed-up to 
arrange the visits. 
The national 
Two-person teams visited sites, generally over the 
course of 
Site 
0 
0 
0 
two days, and engaged in a series of activities. 
visitors were requested to: 
conduct interviews with the drug court coordinator,  drug 
court judge,  probation, defense and district attorneys,  and 
major substance abuse providers 
attend drug court hearings and status reports (and  staffing 
meeting if possible) 
visit major substance abuse treatment program(s1 and obtain 
a list of all service providers 
examine case file record keeping 
obtain copies of assessment/eligibility  paper forms, 
progress reports, etc., for drug court participants 
obtain layout for computer MIS files that contain background 
and program process data 
obtain information on routine criminal justice record 
keeping (arrests,  court processing, probation files) 
obtain copies of existing process/outcome  evaluations 
completed by the site 
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Based on information gathered from these activities, site visitors 
completed for each site a “Drug  Court Evaluation Site Visit Protocol.” 
This protocol was developed in order to capture similar information 
across all 14 sites.  A series of individual questions in major domains 
relating to program model; general program characteristics;  client flow, 
eligibility, and characteristics; staffing;  environment/context;  funding 
and costs; provision of treatment and other services; reinforcements, 
punishments, rewards, and sanctions; intensity; rehabilitative  versus 
surveillance  philosophy; monitoring and supervision; linkage and 
collaboration; administrative leadership and cooperation; program 
implementation; implementation  barriers; and “evaluability”  were 
completed for each program (see  copy of protocol in the Appendix). 
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V.  DRUG COURT PROGRAM IMPLEMENTATION 
Each of the 14 drug courts had been operational for at least 
several years at the time of our site visits and data collection. 
During the early years of implementation,  many programs had mgde changes 
to various facets of their programs, such as eligibility criteria, 
sanctioning protocol, and treatment providers.  Our information is 
accurate as of the time of our site visits in summer of 1999.8  We 
discuss below program models and general characteristics,  client 
characteristics, treatment provision and other services,  behavioral 
demands on drug court participants, funding, linkage and collaboration, 
rehabilitation  vs. surveillance,  and major changes drug courts have 
experienced during their implementation. 
PROGRAM MODEL AND  GENERAL CHARACTERISTICS 
The majority of  the arug court programs were designed for adult 
offenders.  Programs in two sites, Tampa and Chicago,  were designed for 
juvenile offenders.  Consistent with Key Component #3 (DCPO  key elements 
1997), all prcgrams intercepted eligible offenders early in the process 
after arrest, either pre-plea or post-plea offenders.  The post plea 
model was the most common.  In this case, offenders pleaded guilty to 
charges and agreed to participate in the drug court,  with charges being 
dismissed upon successful completion.  In many cases, the models were 
not "pure"  pre-plea,  post-plea, or post-adjudication (probation) 
programs.  In these cases, it appeared that the referral process had 
been relaxed, allowing offenders at other stages of adjudication or 
supervision  access to the drug court and its services.  A minority of 
sites consider offenders on probation. 
violators, referrals from probation officers, or even dispositions by 
These could be probation 
a  We suspect that additional changes may have occurred since our 
site visits. 
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judges that offenders participate in drug court as a condition of their 
probation. 
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Table 5.1  f 
Program Model and General Program Characteristics 
Target 
Site  Group  Model  Other programs  Capa  ci  t  y  Stages of intervention 
Atlanta 
Birmingham 
Brooklyn 
Chicago 
Kankakee 
Omaha 
Riverside 
Roanoke 
Sacramento 
San Juan 
Adults 
Adult 
Adul  t 
Juvenile 
Adult 
Adult 
Young 
Adult 
Adult 
Adult 
Adult 
Santa Barbara  Adult 
Spokane  Adul  t 
Tampa  Juven  i  1  e 
Tuscaloosa  Adu  1  t 
pre-plea.  post- 
plea, post- 
adjudication 
post  -plea 
post  -plea 
post  -plea 
post  -plea 
post  -plea 
post-plea, 
probat  ion 
post  -plea 
post  -plea 
pre-plea,  post- 
plea, probat  ion 
post-plea 
pre-plea 
pre-plea 
pre-plea,  post- 
no other drug 
programs; 2 
other diversion 
Breaking the 
Cycle; deferral 
program for low 
level drug 
offenders,  TASC 
DTAP, TAS'C 
Drug School 
TASC 
routine 
divers  ion 
low-level drug 
diversion 
day reporting 
low-level drug 
divers  ion 
TASC 
low level drug 
diversion 
TASC 
arbitration; 
drug education/ 
UA 
approx 100 
380 
approx 400 
approx 90 
60 
approx 300 
75 
approx 85 
150-200 
150 
220 
50 
280 
300 
5 stages, 12-18  months 
3  phases, 12 months, monitoring 
by TASC 
3  phases, 8-18  months, 
monitoring by court-based  case 
managers 
2  phases, 9-18  months, 
monitoring by TASC 
3 stages,  12-24  months 
3  phases, 12-18  months 
2 phases, 12-16  months 
4  phases, 12-18  months 
4  phases, 12-14  months 
18 months, TASC monitoring 
5 phases, 18-24  months 
5 phases, 12 months, monitoring 
by TASC 
4 phases, 9 months 
4  phases, up to 24 months 
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Drug courts operate in complicated local contexts.  Most drug 
courts operate in environments in which diversion  programs or other 
programs designed for drug of  fenders exist. 
programsg  were operational in several sites.  In some cases, these 
programs drain potential clients from the drug court program.  For 
example, in California,  Penal Code 1000 (PC1000)  serves as a diversion 
program for low-level  drug offenders.  In Chicago, the "drug  school"  for 
juveniles targets low level first time drug offenders with small 
possession amounts.  In Brooklyn, select offenders are offered a spot in 
the District Attorney sponsored DTAP program that provides intensive 
residential treatment with dismissal of charges.  TASC operates for 
adult felony offenders  who face six months or more of jail or prison 
time, and a three-day  Treatment Readiness Program (TRP)  is available for 
Long standing TASC 
female  defendants sentenced on misdemeanor charges at arraignment. 
The 14 drug court programs generally handled a small number of 
drug offenders in any given jurisdiction.  For six of the programs, 
capacity was 100 or less.  During our site visits we requested 
information on the percentage of drug-involved  offenders that might be 
eligible for drug court and the percent of those referred  who actually 
ended up in the court.  We did this to estimate the potential impact on 
case processing in the jurisdictions.  Although many jurisdictions  did 
not routinely collect this information,  sites indicated a wide range of 
responses to this question.  In some jurisdictions, only a small 
percentage of drug-involved offenders were eligible for the program, due 
to the screening criteria (e.g.,  violence).  In several, up to 50 
percent were eligible.  In few instances,  however, did the percent of 
eligibles actually placed into drug court exceed 50 percent.  Overall, 
TASC  (originally  Treatment Alternatives to Street Crime) serves 
as a bridge between the drug treatment community and the criminal 
justice system.  TASC programs were developed in the 1970s  to provide 
monitoring, brokering, and court reporting functions for drug-involved 
offenders. 
This document is a research report submitted to the U.S. Department of Justice. This report has
not been published by the Department. Opinions or points of view expressed are those of the
author(s) and do not necessarily reflect the official position or policies of the U.S. Department of
Justice.-  20 - 
the major reason for small percentages of drug-involved offenders 
actually participating in drug court is exclusionary criteria, discussed 
in more detail below.  As a result,  drug court programs, by design, do 
not cast a wide net for drug-using offenders.  They often appear to fill 
a niche between programs offered to the lowest level drug offender and 
more serious offenders  with histories of violence. 
Most of the 14 studied drug court programs used a staged,  or 
phased, intervention  model, consisting of intensive monitoring, 
treatment, and court appearances during the early months, followed by 
less intensive monitoring and treatment.  The majority lasted between 12 
and 24 months.  Many included a short initial period for assessment and 
final eligibility determination.  The timing and length of phases pften 
was tied to the drug treatment components of the program, refllecting the 
focus on treatment and recovery of the drug court programs. 
CLIENT SCREENING AND ELIGXBILITY CHARACTERISTICS 
Table 5.2 presents major screening criteria for drug court 
offenders.  Jurisdictions differed in the types of offenders eligible 
for programs, but generally required some kind of a drug charge or 
property offense that is related to or motivated by drugs.  Some 
jurisdictions allowed both misdemeanors and felonies; others were for' 
felonies only.  In many instances, it was the exclusionary criteria that 
shaped the nature of the drug court clients to a large degree.  Table 
5.2 lists the major exclusionary criteria for the different sites, 
although in several,  the list of exclusions was quite lengthy. 
Reflecting DCPO  requirements,  violent offenders were excluded from these 
14 drug court programs.  In many instances, offenders with drug sales 
and trafficking  were also excluded.  Other exclusionary criteria include 
weapon possession,  gang involvement,  and mental illness.  Cases were 
initially referred by a wide variety of criminal justice actors, 
including judges,  public defenders, and arresting officers,  often 
through a multiple gating screening process.  However, in the great 
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majority of  jurisdictions, the district  (or  state's1,attorney  was the 
primary referral source. 
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Table 5.2 
Client Screening and Eligibility Characteristics 
Eligible  Ref  erra  1  Primary drug use 
Site  offenses  Exclusions  Source  Cri  t  eri  a  of offenders 
Atlanta  drug crimes; 
drug-related 
property crimes 
Birmingham 
Brook  1  yn 
Chicago 
Kankakee 
Omaha 
drug possession 
felony drug 
charge 
drug possession; 
theft; property 
crimes 
drug or property 
crimes 
non-violent 
felony 
current and prior 
violent crime; dual 
diagnosis; homeless; 
unmotivated offenders 
drug sales;  violent 
history; weapon in 
current arrest 
prior convictio?,  or 
pending charge for 
violent felony; 
pending charges for 
violent felony or 
misdemeanor; DA 
exclusions for certain 
cases 
prior or pending 
violent offense; 
first-time arrestees 
diverted to "drug 
s  c  ho  o  1  '' 
current violent 
charge;  history of 
violence 
more than 1  prior 
felony;  prior 
conviction for violent 
felony; multiple 
misdemeanors for 
violent offenses; gang 
judges  ;  drug  marijuana; crack 
city  dependency  cocaine 
attorney  ; 
pretrial 
defense  not  alcohol; crack 
attorneys  specific  cocaine 
apply 
arraign-  addicted  heroin;  cocaine 
ment court 
judge 
arresting  drug use or  marijuana; 
officers  desire for  alcohol 
treat  men  t 
judge of  drug-  marijuana; 
custody  dependent  cocaine 
court 
county  moderate or  crack cocaine; 
attorney  high LSI  methamphetamine 
involvement 
(continued  on next page) 
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Table 5.2  (cont'd) 
Client Screening and Eligibility Characteristics 
Eligible  Referral  Primary drug use 
Site  offenses  Exclusions  Source  Cri  t  eria  of offenders 
Riverside  drug felonies  past or current  public  drug abuse  methamphetamine 
weapons; domestic  defender 
violence; "strikes;"  refers 
gang member; severe  clients to 
psychiatric problems  apply 
Roanoke  non-violent  violent current or  prosecutor  not  alcohol; cocaine 
felony offense  prior offense; drug  specific 
distribution 
Sacramento  drug possession; 
non-violent, 
non-serious 
property crimes; 
probat  ion 
violation 
San Juan  felony drug 
possession; 
aiding a drug 
sale; low-level 
non-violent  drug 
related felonies 
Santa Barbara  misdemeanors and 
felonies with 
drug possession, 
sales,  and drug- 
related theft 
misdemeanor conGict  ion  district 
for weapons or  attorney  ; 
violence;  guns in past  public 
3  years; serious  defender 
felony conviction; 
felony conviction for 
violence or weapons; 
drug sales;  possession 
for sale 
violent offenses;  more  judge 
than minor prior 
record 
violent offenders;  district 
more than 2 felony  attorney 
convictions; drug 
sales 
history or  crack cocaine; 
evidence of  methamphetamine 
abuse or 
addict  ion 
assessed as  cocaine;  heroin; 
" addicted"  mari  j uana 
history of  methamphetamine 
substance 
abuse 
(continued  on next page) 
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Table 5.2  (COnt'd) 
Client Screening and Eligibility Characteristics 
Eligible  Referral  Primary  drug use 
Site  offenses  Exclusions  Source  Cri  t  eri  a  of offenders 
Spokane  drug possession;  additional charges  district  drug abuse/  alcohol; 
drug-related  pending  attorney  dependence  marijuana 
property  problem 
offenses 
Tampa  non-violent  prior felonies 
felony; 
misdemeanor drug 
possession; 
nonviolent drug- 
related crime; 
first-time 
felony offenders 
with drug 
charges 
possession;  nonviolent felony 
drug-related 
, 
Tuscaloosa  non-violent drug  possession of gun in 
case  drug  - marijuana 
managers  dependency 
at  --for  non- 
juvenile  drug crime 
assessment 
center; 
state 
attorney 
district  accepted by  marijuana 
attorney  treatment 
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Criteria for drug dependency were less formally specified than 
offense and prior record criteria and were often evaluated later--often 
by treatment providers during the initial phases of the drug court 
program.  Virtually all of these 14 drug courts required some evidence 
of addiction or drug dependency,  although in Chicago,  youth needed only 
to indicate a desire for treatment to satisfy the drug use criteria. 
Birmingham accepts clients involved only slightly  with drugs (e.g., 
charged with false prescriptions) as an early prevention/intervention 
program to curb potential regular use or abuse.  Primary drug use varied 
across the sites, often reflecting  drug use trends across the country 
(Office  of National Drug Control Strategy 2000).  Methamphetamine was 
the primary drug in western sites,  although the great majority of sites 
had offenders that use cocaine and marijuana. 
DRUG COURT TEAM 
Table 5.3 presents key factors related to the drug court team and 
hearings.  One usually thinks of drug courts as separate courts with 
assigned drug court judges.  In the vast majority of the sites, this was 
the case.  However, in two sites, the usual model did not apply.  In 
Chicago,  drug court cases were actually heard in arraignment court, 
interleaved with other cases.  Drug court offenders  were not seen 
separately as a group.  In Riverside, drug court cases were held in a 
court in which other drug cases also appear. 
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Table 5.3 
Drug Court  Team 
Frequency  of 
Dedi  ca  t  ed  Offender 
Site  Drug Court  Staffing  Appearance  San  c  t  i  on  s  Rewards 
Atlanta  Yes  Director  weekly at  after 1st  reduction in 
2 Supervisors  first;  then  positive UA,  appearances before 
4  Case Managers  once every 2-4  increasing jail  DC; verbal praise 
MIS specialist  weeks  (3,5,7,  10-14),  from judge 
then inpatient  ~ 
p  1  ac  emen  t 
Birmingham  Yes  Supervisor  weekly at  1st positive UA:  reduction in 
2 Case Managers  -,  first; then  1 day in jail  appearances before 
(if clean)  2nd: weekend  DC;  verbal praise 
once every 2  from judge in 
weeks, once  front of other DC 
every 3 weeks  observers and 
3rd: week 
participants 
Brook  1  yn  Yes  Assistant DA  once a month  graduated: court  reduction in 
Legal Aid Defense Attorney  appearance with  supervision/treat- 
Project Director  jail after 3rd  ment intensity  ; 
Research Associate  infraction  gift of a journal  - 
Deputy Project Director 
Network Clinical Director 
Case Managers 
Resource Coordinator 
Laboratory Technician 
2 TASC  treatment,  appear in court; 
4 Probation Officers  detention as last  incentives (movie 
State Attorney  resort  passes, t-shirts, 
Public Defender  tickets to sports 
Chicago  No  Administrator  once or twice  increase UA,  more  not having to 
events) . 
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Table 5.3  (cont'd) 
Drug Court Team 
Frequency of 
Of  fender  Dedi  ca  t  ed 
Site  Drug Court  Staffing  Appearance  Sanc  t  i  on  s  Rewards 
Kankakee  Yes  Administrator  every two  1st violation:-- 
State's Attorney  weeks at  penalty box 
Probation Officer  first, then  2nd: 24-hour 
Probation Assistant  once a month  shock  - 
Public Defender  incarceration 
3rd: 3 days jail 
4th: 10 days 
5th: 3  weeks jail 
or until 
residential bed 
verbal-  praise, 
handshake from DC 
judge 
certificates  of 
sompletion; less 
frequent court 
appearances; 
reduced UA 
Omaha  Yes  Coordinator  weekly at  more intensive  shorter time in 
Part-Time  Screener  first  , then  treatment; longer  DC; reductions in 
UA and court  2 Case Managers  every 2-4  time in DC; 
Treatment Coordinator  weeks  increased UA;  appearances; 
Part-Time  Lab Technician  increased court  applause from DC 
Administrative Assistant  appearance; 2-day  team and audience 
Deputy County Attorney  jail sentences  in court 
Riverside  No,  DC  Probation Officer  once every  1st: 2 weeks jail  verbal praise; 
cases  Probation Assistant  four weeks,  2nd: lengthy jail  status 
mixed with  Secretary  then once  or discharge  improvements and 
other drug  4 Counselors  every 6-8  3rd: discharge  graduation 
cases  Teacher  weeks  (note  conflicting 
Part-Time  District  info from site) 
Attorney 
Public Defender 
Court Administrator  weekly. then  more treatment;  of drug tests;  - 
Public Defender  bi-weekly,  more community  reduce court 
6 Probation Agents  then monthly  services;  short  appearances 
3 Treatment Staff  (up  to 10 days) 
Drug Court Coordinator  jail sentences 
Part-Time  Lab Assistant 
Roanoke  Yes  Administrator  initially  more frequent UA;  reduce frequency 
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Table 5.3  (cont’d) 
Drug Court  Team 
Frequency of 
Dedi  ca  t  ed  Offender 
Site  Drug Court  Staffing  Appearance  Sanctions  Rewards 
Sacramento  Yes  District Attorney  initially once  1st: 3-8  hours  verbal praise: 
Public Defender  every two  court observation  incentives (stars 
Project Manager  weeks  next 3: 5 days in  for treatment 
Office Assistant  jail, then  behaviors, then 
2 Deputy Probation  increases to  small gifts)  ; 
Officers  10,15,21  days  advancement to 
2 Probation Assistants  jail; termination  next level 
5  Treatment Counselors 
2  Nutritionists 
/Acupuncturists 
3  Case Managers  every 2 weeks,  generally 1st:  handshake; reduced 
Prosecutor  then once a  warning  supervision 
2 Legal Aide Attorneys  month  2nd: curfew or 
San Juan  Yes  Court Clerk  initially  case-by-case;  verbal praise; 
residential 
treatment.  Short 
jail also used. 
Santa Barbara  Yes  Probation Officer  initially once  graduated  verbal praise in 
Part-Time  Supervising PO  a week, then 2  sanctions on  court 
Psychologist  times a month  case-by-case.  certificates of 
Vocational Counselor  Sanctions range  completion of each 
4 Case Managers  from overnight to  phase 
2  Treatment Supervisors  30-45  days in  reduced curfew 
District Attorney  jail, increased 
Representative  meetings  , 
Public Defender (this  is  curfews, in- 
€or 1 of the 2 courts)  custody treatment 
(continued  on next page) 
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Table 5.3  (cont'd) 
Drug Court  Team 
Frequency of 
Dedi  ca t  ed  Offender 
Site  Drug  Court  Staffing  Appea  ran  ce  Sanctions  Rewards 
Spokane  Yes  TASC Case Manager  initially once  flexible;  start  verbal praise in 
Treatment Counselor  a week,-  then  with community  court: sobriety 
2  Part-Time  DOC Officers  once a month  services,  medallions; 
District Attorney  increased NA/AA  -  shorter, less 
Public Defender  attendance,  intrusive home 
increased case  visits 
manager contacts, 
work release, 
jail time 
Tampa  Yes  2  Juvenile Drug Court  every two  repeating a  public recognition 
Specialists  weeks  treatment phase;  and praise in 
District Attorney  more UA; SHOCK  court; less 
Case Manager  education  monitoring; attend 
Treatment Provider  (intensive  day  court 1  e  s  s 
treatment)  ;  frequently 
detention in 
regional juvenile 
detention center 
Tuscaloosa  Yes  Court Administrator  initially,  graduated,  applause from DC 
2 Case Managers  once a week  ranging from  for progress;  more 
Treatment Specialist  overnight stays  freedom of 
Coordinator  in jail to a  movement; less 
Drug Court Coordinator  week, repeat a  reporting; 
stage of  certificate of 
treatment  completion for 
each stage 
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As shown in Table 5.3,  drug courts are labor intensive.  When we 
asked drug court sites to indicate the number and types of persons,who 
make up the drug court staff,  most sites indicated a large drug court 
team, consisting not only of the drug court judge, but also probation 
staff, drug court administrators,  case managers, public defenders, 
district attorneys,  TASC staff,  and sometimes treatment providers and 
other treatment brokers.  These memders may not all be paid from drug 
court program funds (in  many cases, time was donated in kind--we  discuss 
fiscal issues later).  Staff  meetings before actual drug court sessions  , 
often involved the drug court team meeting to review cases and suggest 
appropriate rewards and sanctions for the participant's performance. 
One of the key components of effective drug court programs,is', 
ongoing judicial interaction with each drug court participant!  Regular 
status hearings should be used to monitor the participant's performance, 
with increases or decreases in the time between status hearings based on 
compliance with treatment  .:  Sites demonstrated a wide range of regularly 
scheduled status hearings.  In seven drug courts,  participants initially 
appeared weekly; in three sites,  every two weeks; in three, once a 
month.  In Chicago,  youth appeared before the judge only once or twice 
during their entire participation in drug court; reports to the judge 
were made by other drug court program staff,  without the youth being 
present, unless performance was an issue.  Scheduled hearings were 
generally reduced for satisfactory performance.  The actual amount of 
time a participant spends in front of the judge can be quite short. 
During site visits, visitors were able to observe drug court sessions at 
a number of the 14 sites; appearances before the judge lasted only a few 
minutes in many cases. 
One of  the defining characteristics  of drug courts is the 
application of appropriate rewards and sanctions for  participant 
behavior.  Drug courts should establish a coordinated strategy, 
including a continuum of responses, to continuing drug use and other 
non-compliant behavior.  Sanctions can typically include warnings, 
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repetition of phases, increased testing, confinement in the courtroom or 
jury box, increased treatment, increasing period of jail confinement, 
and finally termination  (Drug  Courts Program Office 1997, pp. 24-25). 
The 14 drug court programs articulated various strategies for how they 
dealt with non-compliance. 
noncompliance  was addressed.  In a minority of sites,  jail stays were 
used fairly early in the escalation of sanctions.  Other programs 
appeared to offer increased treatment and other monitoring before jail 
terms were used. 
bo  major differences appeared inahow 
Despite articulated protocols for sanctions,  our discussions  with 
drug court staff revealed that, in practice, the application of 
sanctions  was often done on a case-by-case  basis, depending on the 
characteristics  of the offender and the behavior.  Sanction options were 
often recommended by the case manager or probation officer and discussed 
at pre-drug court staff meetings by  the drug court team.  Ultimately, it 
was the judge who decided'the  sanction to be applied.  Although the list 
of possible sanctions might be provided to drug court participants, 
there was often no strict "graduated"  protocol that was followed. 
For many drug court programs, the ultimate reward for successful 
performance is the dismissal of the offender's charges.  However, during 
drug court participation, other mid-term rewards are often used. 
Encouragement and praise from the bench, ceremonies and tokens for 
accomplishment,  reduced supervision and monitoring,  and reduced fines 
may be used for an offender's accomplishments (Drug  Courts Program 
Office 1997,  p. 24).  In the 14 sites,  verbal praise from the judge, 
and handshakes from the judge,  were often used.  In several 
jurisdictions,  special tokens, certificates,  and incentives marked good 
performance.  In all sites, some form of reduced supervision--decreased 
court appearances,  monitoring, or less reporting--were  used as rewards 
for positive performance.  In our discussions with drug court staff, the 
application of  rewards did not appear to receive the same amount of 
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attention or scrutiny as did sanctions,  perhaps because issues of 
liberty  (imposed jail) or program failure were not at stake. 
TREATMENT PROVISION AND OTHER  SERVICES 
A major partner in drug courts is the local treatment system.  The 
treatment component of drug court programs provides much of  the non- 
adversarial,  therapeutic underpinning of the drug court model. 
Treatment providers conduct assessment and case planning, and provide 
'  treatment services,  as well as provision/referral to ancillary services 
such as employment,  housing, education, and mental health services.  In 
addition, they often serve as the gatekeeper for a participant's 
progress through the stages of  the drug court program,  providing 
performance feedback to the court.  Table 5.4 presents major dimensions 
of  treatment services in the 14 participating sites. 
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Table 5.4 
Treatment and Other Services 
Type of D&A 
Screening and  Treatment  Other Services  Trea  tmen  t 
Site  Asses  smen  t  Available  Avai  lab1  e  Availabil  i  ty  UA  Monitoring 
Atlanta  NEEDS 
Birmingham  TASC 
Brook  1  yn  clinical 
assessment 
in  t  ervi  ew 
Chicago 
Kankakee 
Omaha 
TASC conducts 
ASAM 
SASI, DSM-  IV, 
inhouse form 
LSI and 
others 
Rivers  i  de  ASI, 
psychosocial 
OP 
OP 
referral, housing and 
job services 
referral, housing 
OP,IP,D,M  onsite supplemental 
social services, health 
screening,  vocational 
and educational 
referrals 
OP,  IP  referral 
OP,  IP,D  referral 
OP.  IP  referral 
OP,  IP,  D  day care, residential 
services, education; 
tx funding is 
limited 
readily available 
available,  except 
for dual diagnosis 
generally 
available,  except 
for female 
residential 
available, some 
wait for inpatient 
waiting lists 
available,  except 
for residential 
3 X  /week 
varied, random 
schedule 
prior to court 
hearing; as needed 
by tx (up  to 2x/ 
week) 
weekly, on random 
basis by TASC; as 
needed by tx 
l-2x/week  by case 
manager; weekly 
random by tx 
by DC staff at 
s c  hedu  1  e 
appointments 
weekly random 
referral to others 
Note: OP-outpatient; IP=inpatient;  D=detox;  M=methadone;  A=Acupuncture;  TC=therapeutic community 
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Table 5.4  (cont'd) 
Treatment and Other Services 
Type of D&A 
Screening  and  Treatment  Other Services  Trea  tmen t 
Site  Assessment  Avai  1  ab1  e  Avai  1  ab1  e  Ava i  1  abi  1 i  t  y  UA Monitoring 
Roanoke  AS I  OP,D,IP,TC  referral  limitation in  3x/week 
residential, 
intensive,  and 
employment 
San Juan  random 
Sacramento  medical  OP,  IP,D,A  referrals  limitations in  3x/week random 
screen/ heath  residential and 
quest  ion-  detox 
naire 
AS1 plus  OP,IP,D,A  referral  available 
other 
medical, 
ical 
Santa Barbara  ASI, risk/  OP,D,A  referral  limitations on  1X/mo in field by 
needs  residential beds  probation; random 
assessment  weekly in tx 
assessment"  ; 
tx provider, 
ASAM 
pscyholog- 
Spokane  TASC "needs  OP,  IP,  D  referral  sufficient  2X week, initially 
Tampa  POSIT  OP,  IP,D  referral  1  imi  ted;  varies, up to 
residential, mental  3X/week 
health services,  OP  ~ 
Tuscaloosa  clinical  OP,  IP  referral  limitations,  varies, up to 
assessment  especially or  3x/week 
residential beds 
Note: OP-outpatient; IP=inpatient;  D=detox;  M=methadone;  A=Acupuncture;  TC=therapeutic  community 
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Assessment is often the first task conducted for appropriate 
treatment planning.  All programs conducted some kind of an assessment 
of drug court participants,  although the tools varied widely.  Some 
programs used well-established tools such as the ASAM  (American  Society 
of Addiction Medicine) or AS1  (Addiction  Severity Index) that have been 
validated.  Others used more locally-created  instruments,  which may be 
paired with standardized instruments or used'alone. It was not uncommon 
for a case manager, such as TASC, to conduct an initial assessment, 
followed by assessments conducted at the treatment provider program. The 
assessment instruments typically measured behavioral and psychosocial 
domains beyond drug and alcohol involvement,  often including medical 
screening,  education and employment needs, and housing and child cere 
issues. 
The most common treatment modality available to drug court 
participants at all sites was outpatient treatment.  This reflects the 
fact that outpatient treatment is generally the most common in 
jurisdictions,  and that offenders with severe disorders (dually- 
diagnosed) were often excluded by eligibility criteria.  In many of the 
sites, inpatient or residential beds were available to a limited number 
of participants,  and are often used when offenders did not perform well 
in outpatient programs.  In a few jurisdictions,  detox services  were 
part of drug court treatment,  as was acupuncture (used to facilitate 
treatment). 
jurisdiction for residential/inpatient  slots; outpatient slots were 
generally available. 
Treatment availability appeared hampered in virtually every 
Coupled with the drug treatment needs,  many offenders are in need 
of ancillary services such as housing, employment,  education, and health 
care.  These services were rarely performed directly by the drug court. 
In some instances. drug and alcohol treatment providers may provide 
them.  More generally,  offenders were referred to external community 
agencies for these services.  In some cases, the drug court was able to 
pay for the services; in a great many cases,  public funds (e.g., 
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Medicaid) were tapped or participants were asked to pay on a sliding- 
scale €or services. 
Urinalysis monitoring is designed to provide accurate and rapid 
information about an offender's drug use.  The 14 sites varied a great 
deal in their drug testing regimens,  both across sites and within a 
site.  Within sites,  drug testing frequency  was often tied to the phase 
of treatment.  Earlier,  more intensive phases had higher testing rates. 
The most frequent schedule was 2-3  times per week, frequent enough to 
detect ongoing drug use.  Testing was conducted not only by treatment 
providers,  but often by the case managers (e.g.,  TASC,  probation 
officers).  In some instances, information from UA tests in treatment 
was not shared routinely  with the drug court. 
During our site visits we requested information on the involvement 
of  the judge in the treatment decisions for individual clients. 
Although judges have the ultimate decision regarding an offender's 
behaviors and progress, treatment providers (and/or  treatment case 
managers) have a great deal of influence in the drug court.  In 
virtually every jurisdiction,  treatment staff recommendations regarding 
treatment  (often  including phase advancement)  were generally agreed to 
by the judge. 
BEHAVIORAL DEMANDS ON DRUG COURT PARTICIPANTS 
The behavioral demands placed upon drug court participants are 
displayed in Table 5.5.  These were in addition to the drug court 
appearances and urinalysis requirements described earlier.  Drug court 
participants had to attend drug and alcohol treatment, meet with their 
case managers and probation officers (if  applicable),  complete other 
service requirements,  and often pay for drug court and treatment 
services.  Ultimately they must complete the graduation requirements in 
order to have their cases dismissed (at least for post-plea models). 
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Table 5.5 
Behavioral Demands on Drug Court Participants 
Graduation 
Site  Treatment  Case Manager  Probation  Other  Costs  Requirements 
At  1  anta  40 hrs/week  weekly  NA  $375--treatment  complete 12-18  mo 
program: attend 
UA-for 6  mo; no 
re-arrest 
-  treatment,  clean 
Birmingham  daily NA/AA  weekly  100 hrs  $1500 drug  complete DC 
-communi  t  y  court; $20 each  requirements,  and 
service  day/ jail: $5  at least 10 months 
each submitted  drug free 
urine 
Brooklyn  5X  /week*  1X/2  weeks  NA  community  no  direct  complete treatment 
service  client fees  phases and 
placement  progress toward 
completing "life 
goals"  ; community 
service,  other 
court requirement 
Chicago  3 hrs/week  (done  by  weekly  no direct fees  completion  of 
(outpatient)  probation)  treatment,  testing 
clean, avoiding 
re-arres  t 
Kankakee  1 group; 1  (done  by  l-3X/week  complete  $3-$23  per  complete treatment 
individual  probation)  GED/educational  group 
counseling, 2  requirements  $5.50-$60  per 
NA/AA mtgs/  individual 
week  session 
*  contacts vary by "band"  of treatment; band 5 (day  treatment) used as example 
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Table 5.5  (cont'd) 
Behavioral Demands on Drug Court Participants 
Gradua t  ion 
Site  Treatment  Case Manager  Probation  Other  costs  Requirements 
Omaha  va  r  i  ab  1  e  once a week  NA  $460 DC fee;  complete treatment 
treatment co-  and support 
pays  ;  groups; 6 months 
$10 per  clean UAs;6 months 
positive UA  employment; 
appearances at DC; 
no new 
felony/serious 
Riverside  7.5  hrsl day;  daily  daily  education at day  $100  completion of 
5 days/week;  treatment  treatment, 
rema  in  ing  3 NA/AA per 
week  abstinent 
Roanoke  3X  /week  3-5 times  NA  curfews  $150  completion of 
per week  treatment,  no 
positive UAs for 6 
months; secure 
employment,  pay 
court costs and tx 
fee 
as needed  $4  0  /month  treatment-  Sacramento  11.5  hrs/week  (see 
probation)  completion;  no re- 
arrest 
San Juan  day  monthly  2x/month  working/attend-  none  comp  1  et  e 
treatment:  ing school  treatment; no 
10-12  arrests 
session/week 
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Tabla 5.5  (cont’d) 
Behavioral Demands on Drug Court Participants 
Graduation 
Site  Trea  tmen  t  Case Manager  Probation  Other  costs  Requirements 
Santa Barbara  4  hrs/day 5  (see  once a  curfew,  $780  for DC;  treatment 
days  /week  ;  probation)  month  residence checks  $113 for  completion; 
AA/NA 
attendance 
sessions  /  month  month  treatment; $2-3  completion; four 
week; one 
individual  restitution  UAs 
counseling/ 
week; 2 AA/NA 
sessions/week 
Sheriff booking  abstinence,  no 
fees  convictions  or VOP 
Spokane  3  group  twice a  twice a  home visits  co-pay for  treatment 
per UA;  final months clean 
comp  1  et  e 
service  for treatment  treatment;  clean 
UA for 6 months; 
remained in 
school,  obtained 
GED,  or employment 
week; one  UA; restitution  completion;  no new 
family group/  arrests 
week 
Tampa  4-5 hrs/week  once a month  NA  community  sliding scale- 
Tuscaloosa  4 groups/  weekly  NA  employment  $1500; $5 per  treatment 
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initial phase of treatment.  Recognizing that all programs used a 
graduated dpproach,  participants were not required to meet these time 
commitments during the entire course of participation in drug court. 
Some programs initially required only a few hours per week in outpatient 
treatment: others required much more extensive commitments,  particularly 
if a day treatment model was used.  Group and individual sessions  were 
common for outpatient treatment programs, as was attendance at AA/NA 
meetings.  Contact with a case manager--sometimes case management is 
performed by probation--was  often weekly during the initial phases of 
the drug court participation, although in some programs it was once or 
twice a month.  Again, if a day treatment model was used, contact pith 
the case manager or probation officer can be performed much more 
frequently--as  often as daily.  In some instances an additional 
requirement for the completion of community service was attached to the 
drug court program.  Finaily, the graduation components of most programs 
were similar: successful completion of treatment, often with the 
additional requirements of testing clean for drug use and remaining 
crime free. 
+ 
Drug Court participation may not be free.  As Table 5.5  shows, 
some programs required fees not only for the drug court itself, but also 
for urinalysis testing and treatment. The latter costs were often 
small--paid  either by a co-payment or sliding scale,  reflecting the 
routine practice of  treatment programs charging clients. 
FUNDING/EXPENDITURES FOR DRUG COURT PROGRAMS 
During our site visits, we requested information on drug court 
funding and budgets.  This information was gathered to help understand 
how programs were funded and to determine whether individual participant 
expense data were available for analyses of the costs of drug court 
programs.  At the time of our visits,  many drug court programs were 
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coming to the end of their DCPO grants, or had moved entirely off  DCPO 
to other types of funding. 
Although a few drug court programs (generally  smaller capacity 
programs) were funded completely from  DCPO grant funds, the vast 
majority cobbled together a funding base consisting not only of  the DCPO 
grants, but also funds from other federal grants (e.g.,  Violent Offender 
Incarceration/Truth-in-Sentencing, law enforcement block grants, HIDTA, 
CSAT), from state and county funding,  or from state court systems.  Many 
relied on the collection of client fees,  reimbursements from AFDC, 
general relief,  medicare, and managed care.  It was not uncommon for 
office space and personnel to be donated as in-kind  contributions €or 
drug court operations.  Generally the larger programs were the ones with 
the most diversified funding bases, as might be expected,  given their 
larger operating costs. 
Although many sites were able to provide overall expenditures for 
their drug court programs,,  at no site were we able to obtain 
expenditures for drug court program services at the individual level. 
For some sites,  aggregate costs for urinalysis testing, counseling,  case 
management, etc., were available.  Rough calculations of "per  offender" 
costs can be calculated by dividing aggregate costs by the numbers of 
drug court participants. 
LINKAGE AND COLLABORATION 
Linkages and collaborations are central to drug court programs 
that bring together many agencies and programs.  In four of the drug 
court programs,  TASC was a key component of the linkage process.  In 
these programs,  a long standing "bridge"  between the courts and 
treatment programs had been incorporated into the drug court model. 
TASC facilitated the smooth start up of the drug court model in at least 
one site. 
Formal linkages appeared to exist primarily with substance abuse 
treatment providers.  Other services  were provided on a more informal 
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,e 
basis, often through referral.  Communication, in the sense of getting 
information about changes in the drug court program process, appeared to 
occur informally.  Communication "as  needed" appeared to characterize, 
the transmission of information to involved parties.  Although meetings 
provided a somewhat more formal vehicle at some sites, it is not clear 
whether communication was sufficient from the perspective of the 
treatment providers. 
information were cited as problems.  In some instances, information was 
shared sparingly in an effort to protect the confidentiality  of clients 
In an era where management information  systems are critical to 
\ 
4 
Lack of ef  f  iciehcy and kegularity in sharing of 
I 
effective information sharing, few of the drug courts had sufficient 
resources in this regard.  Some programs had systems that serve ontsite 
needs; others had no MIS systems.  There was no evidence'of  any programs 
having systems that were networked to other providers and that could 
provide relevant agencies with immediate access to client information. 
REHABILITATION VS.  SURVEILLANCE 
One of the key characteristics of a treatment drug court is the 
emphasis placed on rehabilitation.  This was clearly seen in our 
discussions with drug court team members across the 14 jurisdictions. 
In discussions with judges, some indicated that the role of drug court 
judge was a major change in orientation for them from the traditional 
adversarial role.  At the same time,  however, many drug court team 
members felt that drug courts must strike a balance between 
rehabilitation and surveillance.  A "carrot"  and a "stick"  approach was 
seen as necessary to encourage treatment participation and law abiding 
behavior.  The "stick"  however,  was interpreted differently  across sites 
(as  seen in the sanctions discussed above).  Some sites mentioned a lot 
more leeway in responding to violations with sanctions, and thus 
appeared to lean more toward the rehabilitative end of the continuum. 
In a few jurisdictions,  staff were concerned about the severity of 
sanctions "scaring  away"  volunteer drug court clients.  In several 
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beliefs about the importance of rehabilitative  and surveillance in their 
programs.  For example,  in some sites,  public defenders and treatment 
representatives favored a more a=-  rehabilitative focus, district 
attorneys,  a more public safety role. 
4 
CHANGES DRUG COURTS HAVE  EXPERIENCEb 
Most programs indicated that changes had occurred during drug 
court program implementation. 
areas: changes in drug court team composition, treatment provision, 
eligibility requirements,  and low numbers of  eligible offenders actually 
entering the program.  In two sites, the entire drug court program was 
moved from one agency to another; in others, original tern members 
The most common changes occurred in four 
I 
either pulled out of the drug court or were unwilling to participate in 
the collaborative as planned.  In some instances treatment services did 
not want to participate due to the perceived seriousness  of  the drug 
court participants.  Treatment issues (lack  of control over decisions 
regarding treatment completion) were so great in one site that the 
program brought the treatment "inside,"  provided through day treatment. 
In some programs,  participant eligibility criteria were loosened  (often 
to help make up for low numbers of participants); in other instances,' 
they were tightened. 
When asked about implementation  hurdles and issues that need to be 
resolved,  management information systems,  continued funding,  and 
coordination of key players were major themes.  Nine of the 14 
jurisdictions  mentioned the lack of an integrated management information 
system as an ongoing issue for their drug court programs.  Continued 
funding for the drug court and/or treatment services was mentioned by 
eight of the programs.  Nine programs indicated that establishing and 
maintaining collaborative relationships  with other components of the 
justice and treatment systems was an ongoing concern.  The nature of the 
collaborative issues varied.  In some jurisdictions,  district attorneys 
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were seen as having too much control over the drug court process, 
especially in determining eligibility.  In others, lack of community 
support had to be faced. 
players and oversight committees remained an issue.  Staff turnover, 
rotating judges, and even personalities were also mentioned. 
In some, simply coordinating with drug court 
Two  major themes emerged as ways to overcome these problems.  Many 
drug court staff stressed the importance of a careful pre-implementation 
planning process that worked to resolve issues related to eligibility, 
treatment, sanctions, and interagency coordination.  The other theme was 
the need for a lead agency to be selected that would assume primarily 
responsibility for the drug court.  A strong leader, often the drug 
court judge himself/herself,  was seen as key to making the drug court 
collaborative successful. 
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VI.  A  CONCEPTUAL FRAMEWORK" 
The second major task for our evaluation was the development of a 
conceptual framework for drug courts.  We began by reviewing existing 
drug court evaluations.  Our review suggested no currently available 
unifying perspective (or,  short,  of that, a set of competing 
perspectives) regarding the structural and process characteristics of 
,  drug courts.  Limitations  were found in a number of efforts.  Literature 
'reviews  collated and synthesized information on drug courts with 
specific questions regarding structure and process in mind.  But 
structure and process are not described fully, if at all, in many drug 
court evaluations,  and the information they do provide is often not 
amenable to comparison (Goldkamp  1999).  An  alternative to relying on 
finished evaluations is to use the raw data being compiled by the Drug 
Court Clearinghouse and Technical Assistance Project at American 
University.  Although the database provides an extensive and very useful 
listing of program characteristics,  it has no organizing theoretical or 
conceptual scheme.  The best-known conceptualization of drug courts may 
be the "ten  components"  specified  by the National Association of Drug 
Court Professionals  (Drug  Courts Program Office 1997).  The components 
offer a systematic view of drug court structure and process.  However, 
their purpose is prescriptive; they are a minimum set of precepts that 
any drug court should follow.  They are not a framework for assessing 
alternative drug court models when each model is (or  in principle could 
be) congruent with the ten components.  Similarly,  Goldkamp (1999)  has 
specified a "uescriptive  typology"  based on seven dimensions of drug 
courts.  As it stands, this typology cannot be straightforwardly applied 
in analyses of drug court structure and process, especially for 
hypothesis testing. 
lo  A version of this chapter has appeared in Journal of Drug Issues 
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We turn now to a drug court typology, or framework, that will 
conceptually define structure and process in ways that are measurable 
and amenable to hypothesis testing.  For maximum value, such a 
perspective must have five features.  First, it must be systematic; it 
must cover all relevant drug court characteristics.  Second, it must be 
parsimonious.  That is,  while covering all relevant dimensions, it must 
also be simple enough to be manageable in analysis.  Third, measures of 
each characteristic  must be amenable to direct comparison across drug 
courts.  Fourth,  measures must reflect structure and process as actually  , 
implemented--not  simply as planned, intended,  or drawn up in memos and 
protocols.  Fifth, a conceptual perspective on drug courts should lead 
to hypotheses that are testable and relevant to policy and practice. 
For example,,are  outcomes more favorable in drug courts quicx to impose 
severe consequences for noncompliance than in courts more patient with 
noncompliance?  One hypothesis is that the former sort of drug court is 
more effective  with serious offenders  but is not more effective with 
first-time or lightweight offenders, among whom milder sanctions might 
suffice to produce compliance.  As a final comment on hypotheses,  we 
note that hypothesis testing is more straightforward if drug court 
characteristics are conceptualized and measured with directionality 
(from  less to more or low to high). 
In the conceptual framework proposed here,  we have tried to 
address, or at least to begin addressing, each of  the requirements 
above.  The framework has five  dimensions: leverage,  population 
severity, intensity, predictability, and rehabilitation emphasis  (see 
Table 6.1).  The first two dimensions are structural characteristics  of 
drug court.  Leverage refers to the nature of consequences faced by 
incoming participants if they later fail to meet program requirements 
and are discharged from drug court.  Population severity refers to 
characteristics of offenders deemed eligible to enter drug court.  The 
(Longshore  et al. 2000) 
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other three dimensions are process characteristics.  They describe what 
happens to participants as they proceed through the drug court program. 
Table  6.1 
Conceptual  Framework 
Dimensions of Drug Court 
Structure and Process  Indicators (examples) 
Leverage  Percent of pre-plea and post-plea participants 
Perceived aversiveness of discharge 
'population  severity  Severity of drug use 
Severity of criminal involvement 
(current  charge and prior charges) 
Required frequency of court appearances 
Required hours of treatment 
Conformance of rewards/sanctions  with protocol 
Time elapsed between noncompliance and response 
Perceived predictability 
Program intensity  Required frequency of urine testing 
Predictability  Consistency of rewards and sanctions 
Rehabilitation emphasis  Collaborative  decision-making 
$attention  to multiple needs 
Flexibility in procedure  a 
,  Re-entry 
Drug court dynamics (observed) 
In developing the framework,  we considered the NADCP's  ten 
components (Drug  Courts Program Office 1997); "think  pieces" on drug 
court by Goldkamp (1999),  Harrell (1999),  and the Bureau of Justice 
Assistance (1993);  reviews of the drug court literature (Belenko  1998, 
1999; Inciardi et al. 1996; Terry 1999; U.S. General Accounting Office 
1997); and published and unpublished evaluations of individual drug 
courts.  We also drew from the literatures on criminal deterrence 
(regarding  the dimension we call predictability) and therapeutic 
jurisprudence (regarding  rehabilitation emphasis).  We describe the five 
dimensions and offer examples of empirical indicators for each.  For 
ideas regarding empirical indicators,  we consulted the database compiled 
by the Drug Court Clearinghouse and Technical Assistance Project at 
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American University and drug court monitoring guideli,nes  such as those 
from the Drug Courts Program Office  (1998). 
LEVERAGE 
Leverage refers to the seriousness of consequences faced by 
participants who fail to meet program requirements and are discharged 
from drug court.  Leverage depends, perhaps heavily, on the court's 
entry point--pre-plea,  post-plea,  or probation.  In pre-plea or deferred 
'  prosecution courts, entry to the program occurs before an  offender is 
required to enter a plea.  Upon completion of all program requirements, 
the charge is reduced or dropped.  Pre-plea courts may have limited 
leverage because participants have not pleaded guilty and may have no 
sentence pending.  Moreover, after pre-plea  participants are discharged 
for noncompliance,  the case may be too "cold"  to re-open.  In post-plea 
or deferred judgment courts,  however, entry to the program occurs only 
after an offender pleads guilty.  Upon program completion, the plea can 
be stricken and the case dismissed.  But  if an offender fails the 
program, his/her case moves directly to sentencing and possible 
incarceration.  Thus the stakes are high, and leverage strong,  in a 
post-plea drug court.  Finally, in probation drug courts,  participants 
have a conviction and are entering drug court in lieu of incarceration 
or other sanction.  Probation drug courts may have varying degrees of 
leverage  depending on the seriousness of consequences for program 
failure  n relation to the seriousness of the sanction otherwise 
awaiting the participant.  (It is important to distinguish the 
consequences of program discharge, i.e.,  what happens after offenders 
fail drug court, from the consequences they face during participation in 
drug court.  We refer to the former as leverage.  The latter is 
addressed below.) 
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Leverage Indicators 
The simplest and most objective indicator of leverage is the 
percentage of participants who come to the drug court at the pre- or 
post-plea entry point.  The percentage is of course 100 percent in 
courts with only one or the other entry point, but many courts accept a 
mix of pre- and post-plea cases.  The subjective aspect of leverage, 
i.e., participants' perception of it, may also be important,  especially 
for courts accepting cases on probation.  What do participants believe 
is likely to happen if they are discharged for program failure,  and what 
is the perceived aversiveness of those consequences?  We therefore 
propose both objective and subjective indicators of leverage. 
Our hypothesis is that, other characteristics being equal, 
outcomes will be more favorable  when drug courts have greater leverage 
over participants.  However, courts may be designed for greater leverage 
when the eligible population includes more serious offenders (Drug 
Strategies 1997).  Thus, fhe leverage hypothesis may need to be tested 
within categories of participants.  How does the drug court's degree of 
leverage affect outcomes among lightweight offenders, and, separately, 
how does it affect outcomes among serious offenders? 
POPULATION SEVERITY 
This dimension is based on a distinction between drug courts 
targeting a hardcore population of addicted and persistent offenders 
(one  extreme) and drug courts dealing with lightweight offenders,  whose 
offense history is short and nonviolent and whose drug use is 
"recreational"  (the  other extreme).  The latter may be routed to drug 
court not so much because they need intensive treatment/supervision  but 
because the local criminal justice system views the drug court as a 
welcome new resource for processing cases.  This possibility is perhaps 
most apparent when the target population is first-time or lightweight 
offenders, system resources are stretched thin. and prosecutors are 
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using the drug court essentially as a way to move cases through the 
system.  Of  course many drug court populations fall between the high- to 
low-severity  extremes (Center  for Substance  Abuse Treatment 1996; 
Harrell 1999;  U.S. General Accounting Office 1997). 
population Severity Indicators 
For indicators,  we rely on severity of drug use and criminal 
involvement.  Drug use severity can be assessed as the percentage of 
'  drug court cases that meet  (or  are likely to meet) clinical criteria for 
drug abuse or dependence.  This percentage can be found in records of 
formal screening/diagnostic  assessments employed by the drug court 
and/or  inferred from proxy variables such as participants' prior 
experience in drug abuse treatment.  Criminal severity can be assessed 
on the basis of seriousness of current and past offenses.  For example, 
we can calculate the ratio of felonies to misdemeanors among current 
charges faced by participants on the caseload and the same ratio in 
their criminal records.  (Current  charges and officially recorded 
charges may not accurately reflect the seriousness of acts committed by 
an individual participant, but they do provide an accurate overall 
population severity measure, useful for comparison purposes.)  We can 
also calculate the ratio of cases charged only with drug possession to 
cases charged with non-drug offenses.  For some drug courts, the 
felony/misdemeanor  distinction will not be relevant.  For others, 
notably those that accept offenders with violent criminal histories, 
neither the felony/misdemeanor  distinction nor the drug/non-drug 
distinction will suffice to capture the full range of population 
severity.  It will be necessary to consider relative severity within the 
class of felony offenses. 
The influence of population severity on outcomes may depend on 
other dimensions in the framework.  For example, as suggested above, 
outcomes for a more severe population may be favorable in courts that 
have strong leverage over participants but less favorable in courts 
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where leverage is weaker.  In addition, outcomes for a more severe 
population may be better when program requirements are intensive enough 
(see  below) to have an impact on hardcore offenders.  We therefore offer 
no hypothesis for a main effect of population severity.  We hypothesize 
that its effects are contingent on other factors. 
INTENSITY 
This dimension refers to requirements for participating in and 
'  completing drug court.  These always include urine testing, court 
11,  , 
appearances,  and drug abuse treatment  (Harrell  1999).  Other obligations 
may be imposed as well, such as employment,  suitable housing, completion 
of a G.E.D.,  and payment of fines or restitution.  It is important to 
note that intensity does not refer to requirements actually met by the 
participant.  That is affected by self-selection.  Neither does 
intensity refer to what happens to the noncompliant participant.  That 
too is affected by self-sqlection  in a sense; additional requirements 
are triggered by actions of the participant.  Instead,  we  mean to focus 
cleanly on a dimension of drug court itself: what participants 
understand to be the minimum requirements for program completion. 
Intensity Indicators 
Indicators  of intensity include the required frequency of urine 
testing and court appearances,  required hours of treatment and other 
required services. and fine  and restitution amounts.  Additional 
indicators,  such as an employment requirement, can be handled simply as 
yes/no.  Programs vary in duration (typically  12 to 18 months, sometimes 
longer) and are often broken into phases--more  intensive at first and 
less intensive for compliant participants near program completion.  It 
may therefore be important to measure intensity on a per-month or per- 
phase basis and to take overall duration into account as  well.  For 
intensity data, it may be misleading to rely solely on written or 
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standard protocols.  These may not reflect the requirements to which 
many or most participants are actually held. 
Our hypothesis is that drug courts with more intensive 
requirements  will show more favorable outcomes.  However, along with a 
main effect of intensity,  there may be contingent effects.  A  high 
degree of intensity may be required for success  with a more severe 
population, for  example,  whereas low or modeiate intensity may suffice 
for less severe offenders. 
6 
PREDICTABILITY 
This dimension reflects the degree to which participants know how 
the court will respond if they are compliant or noncompliant (Harrell 
1999).  Goldkamp's  (1999)  concept of client accountability is,  similar, 
but he was referring to the kinds of responses used by a drug court to 
reward good performance and discourage poor performance.  We refer to 
the predictability of the:e  responses. 
deterrence shows that sanctions are more effective if more certain and 
more swift (Blumstein  et al. 1978;  Nagin 1998).  Behavioral research 
says the same thing.  It also suggests that sanctions are more effective 
when people believe they have the opportunity to behave as desired and 
thus avoid the sanction.  Absent this perception, the participant's  ' 
response may be "learned  helplessness" (Seligman  1975).  Marlowe and 
Kirby  (1999) have developed a  number of insights from behavioral 
research specifically  with respect to drug courts.  They argue, for 
example, that the court's expectations should be clear, that actions 
taken by the court should be consistent with expectations,  and that 
delivery of sanctions should be "regular  and immediate" (see  also Drug 
Courts Program Office 1998;  National Drug Court Institute 1999). 
The literature on criminal 
The range and frequency of rewards for good behavior may vary 
among drug courts,  and the rate at which sanctions become more punitive 
(as  in a "graduated  sanctions"  strategy)  may be slow or fast; those 
aspects of drug court are captured in the dimension we call 
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rehabilitation emphasis (see  below).  The ultimate sanction, for program 
failure,  may or may not be dire; that is captured in leverage. 
predictability has to do with whether participants know what the court's 
expectations are, believe their behavior will be detected by the court, 
and know with high probability how the court will respond to their 
behavior. 
Predictability Indicators 
Indicators of predictability may be drawn from court records.  For 
instance,  the court's various responses 4e.g.. counsel, warning, or a 
brief jail sentence) to the first positive urinalysis test can be 
tabulated for all cases with at least one positive test, its respobses 
to the second positive test can be tabulated for all cases with at least 
two positive tests,  and so on.  Courts with less variability in its 
responses to each positive test are more predictable; participants are 
more likely to know what yill probably happen to'them  if they test 
positive once, twice, and so on.  Additional indicators of 
predictability are the percentage of all positive tests that triggered 
some sort of response and, more broadly, the percentage of participants 
for whom the recorded series of responses (both  rewards and punishments) 
conforms to the stipulated protocol.  At the participant level of 
analysis, one indicator of predictability is whether responses to 
multiple positive drug tests steadily increase in severity.  Regarding 
the swiftness of response, one can measure the time elapsed between drug 
use and detection,  the time elapsed between detection and response, the 
time elapsed between other noncompliance (e.g.,  failure to appear in 
court) and response (e.g.,  contact with case manager or arrest). 
Of course it is also possible to assess predictability by asking 
participants, at the outset of their enrollment in drug court and 
periodically thereafter,  to report their views on how likely the various 
rewards and punishments are and how swiftly they will occur. 
Participants' perceptions of procedural fairness--whether  the court 
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"plays  favorites"  or is easily manipulated--may  also be relevant 
(Harrell  1999;  Tyler 1994, 1988).  The court's rulings conform to 
expectations laid out in advance and are consistent across similar 
cases,  participants are likely to view the court as  predictable.  The 
obvious advantage of participant surveys is that they provide,direct 
evidence of predictability as perceived. 
Our hypothesis is that drug court outcomes are more favorable  when 
rewards and sanctions are more predictable. 
REHABILITATION EMPHASIS 
The final dimension in our framework is the emphasis placed on 
rehabilitation  as against other court functions,  including case 
processing and punishment.  This dimension takes on particular 
significance in light of legal philosophies known as restorative justice 
(Braithwaite  1999; Kurki 1999) and therapeutic jurisprudence (Wexler  and 
Winick 1991). in which cri;minal justice is viewed more as a therapeutic 
tool and less as a formalistic and essentially punitive one.  To a 
greater or lesser degree, most drug courts reflect these philosophies 
(Hora  et al. 1999). 
Consider the distinction between expedited drug case management 
courts and drug treatment courts.  The former employ innovative 
procedural rules tailored to drug-using offenders. The latter focus on 
offenders' needs for drug abuse treatment and other services. 
Procedures are less formal in drug treatment courts,  where prosecutors 
and defense attorneys are collaborative or at least less adversarial. 
It is likely that, compared to expedited drug case management courts, 
drug treatment courts place more emphasis on rehabilitation (Hora  et al. 
1999).  However, it is also likely that the emphasis on rehabilitation 
varies considerably even within the range of courts that call themselves 
or operate as drug treatment courts. 
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Rehabilitative Indicators 
Indicators of rehabilitation emphasis  may include the degree to 
which all actors (especially  defense attorneys and treatment providers) 
are involved in deciding how to handle cases, both in review sessions 
and,  more visibly, in court; degree to which time and other resources 
are devoted to multiple needs of participants; degree to which the judge 
and other actors take a therapeutic as distinct from legalistic view of 
their roles; number of positive drug tests typically allowed before the 
court imposes an intermediate sanction (e.g.,  brief jail stay) or  I 
discharges the participant; whether participants who fail the program 
are later allowed to re-enter,  the stringency of re-entry  criteria, and 
the ratio of re-entry  offenders to the total offender population. ' 
Satel's  (1998)  observational indicators of  drug court dyflamid's  also seem 
on point.  These include, for example, the extent to which judges speak 
directly to participants,  make eye contact with participants, and listen 
to what participants have;to say; the amount of time spent by the judge 
with each participant;  proximity of participants to the bench; and 
instances of physical contact between judge and participants. 
\ 
Our hypothesis is that outcomes are more favorable when drug 
courts place more emphasis on rehabilitation. 
RANKING THE 14 PROGRAMS ON THE FIVE DIMENSIONS 
Ideally,  one would record our proposed measures for each site and 
array the programs according to each dimension.  As we have indicated 
previously, the information available from the different sites was often 
incomplete,  particularly on an individual level.  We present here a very 
preliminary ranking of sites on these dimensions.  Our rankings are 
based on information gathered during interviews with program staff,  and 
on reviews of written documentation and protocols. 
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As noted above, leverage  refers to the nature of the consequences 
faced by participants if they later fail the program.  On this 
dimension,  programs that are pre-plea have less leverage than those that 
are post-plea.  Of the 14 programs, 8 are post-plea only programs--we 
considered these ;IS  having high 1everage.l'  In some sites, offenders 
faced prison terms as an alternative to drug'court.  In Roanoke, for 
example, offenders faced prison terms of six months to three years as an 
alternative to participation in drug courtl. Four courts are considered 
"moderate." These moderate programs are the ones that have mixed case 
types--a  combination of pre-plea,  post-plea,  and/or  probation cases.  We 
considered two programs--those  that targeted pre-plea offenders on'ly--as 
having "minimum"  leverage. 
, 
The rankings are relative within the context of the 14 courts 
studied.  If we consider the set of drug court programs as a whole, and 
compare them with other sgntencing alternatives,  a slightly different 
picture emerges.  All drug courts studied exclude violent offenders. 
Many exclude offenders  with drug trafficking or drug dealing charges, or 
with weapons involvement.  In addition,  many jurisdictions have 
diversion programs available for offenders with less serious offenses, 
drug problems, or prior records,  than offenders served by drug courts. 
Thus, as a whole, drug court participants are not the most likely to 
face prison sentences (although  in some sites they do face prison 
terms),  nor are they the most likely to have their cases dismissed. 
Overall, leverage appears to be moderate for drug court as a sentencing 
option. 
We were unable to assess offenders' perceptions of  the 
consequences they faced if discharged, so we do not consider that 
indicator here. 
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population Severity 
As indicated earlier, severity is based on a distinction between 
drug courts that target a hardcore population of addicted and persistent 
offenders (one  extreme), as opposed to those that target offenders whose 
offense history and drug use are light.  In our framework,  we propose 
several measures of drug use and criminal involvement.  Unfortunately, 
we were not able to obtain actual data on these measures for the drug 
courts studied.  We based our initial impressions of offense history on 
eligibility criteria and exclusionary factors;  drug usage level was 
based on the court‘s  criteria for drug use (see  Table 5.2).  In many 
instances,  offenders  with serious  prior records were excluded from 
consideration.  In other sites,  offenders with current misdemeanor 
charges were eligible.  In virtually all sites, offenders had to 
demonstrate some degree of drug dependency or abuse.  In Birmingham, 
however, offenders with very minor drug involvement were eligible; in 
Chicago,  youth could be ascepted into drug court if they expressed a 
desire for drug treatment.  Dually-diagnosed  offenders were often 
excluded,  removing this difficult-to-treat  population from eligibility. 
Based on the information available,  most of the drug courts were 
tentatively rated “moderate”  on the population severity dimension. 
Chicago and Tampa were rated “minimum,“  based partially on the fact that 
they were juvenile programs. 
Program Intensity 
Program intensity refers to requirements for participating in and 
completing drug court.  Urine testing, court appearances, drug abuse 
treatment requirement,  employment,  and payment of  fines and/or 
restitution are all indicators of intensity.  Earlier we noted that it 
is the requirements to which offenders are held--not the actual 
completion (which  may be less than the required intensity)--that  defines 
intensity.  We acknowledge that the officially stated prctocols that we 
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utilized may not accurately reflect the requirements to which many or 
most participants are held. 
Using'the  frequency of drug court appearances (see  Table 5.3), 
stages of intervention  (see  Table 5.1). urinalysis testing (see  Table 
5.4). and the behavioral demands of drug court participants (see  Table 
5.5), we tentatively ranked the 14  programs on program intensity.  Five 
programs were rated "high,"  eight weie rated  '"moderate,"  and one was 
rated minimum.  The minimum ranking was the Chicago drug court,  due to 
very infrequent court appearances before the judge (once  or twice) and 
the relatively light behavioral demands placed upon participants. 
Atlanta, Brooklyn,  Riverside, Roanoke, and Santa Barbara were rated 
"high"  in program intensity,  reflecting in large degree the treatmpnt 
demands placed on offenders,  which varied a great deal more across the 
14 sites than did stated urinalysis testing protocols, length of drug 
court programs, or the frequency of appearances before the drug court. 
Predictability 
Predictability  reflects the degree to which the participants know 
how the court will respond if they are compliant or non-compliant.  As 
described earlier,  measures of predictability include how the court 
responds to dirty urinalysis tests in terms of the consistency and speed 
of responses.  It is also possible to assess predictability by asking 
offenders their experiences with rewards and punishments used in the 
drug court. 
Similar to our rankings on other dimensions, information available 
to us on indicators of predictability was limited.  Our preliminary 
assessment of program predictability was based on responses to items in 
our site visit protocol that addressed reinforcements,  punishments, and 
sanctions.  Sites that indicated they had written protocols €or their 
sanctions, those that indicated they used graduated sanctions,  and those 
that indicated consistent application of sanctions  were considered to 
rank "high"  on this dimension.  Sites that indicated they had no written 
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sanctions and those in which sanctions varied widely were considered to 
be less predictable.  Our preliminary rankings considered six sites as 
"minimum,  'I  five as "moderate,  'I  and three as "high.  I'  In several 
instances, sanctions in place during early program implementation were 
considered inadequate; subsequent program modifications increased the 
severity and certqinty of the sanctions. 
requires a difficult balance in drug courts. '  The courts do not want the 
sanctions to be so onerous that offenders refuse to participate, nor do 
they want them so rigid that discretion €or an individual offender's 
situation cannot be accommodated within the therapeutic environment. 
Application of sanctions 
I 
Rehabilitation Emphasis 
Our final dimension is the emphasis placed on rehabislitation,  as 
against other court functions, including case processing, and 
punishment.  Our framework considers a number of factors, including how 
the drug court team works  ,together, responses to dirty urinalysis tests, 
and interactions  between the participant and drug court judge. 
Unfortunately,  we were unable to gather these types of measures.  For 
our preliminary ratings,  we utilized information gathered from our site 
visit protocol on questions regarding the extent to which key actors 
felt their programs emphasized rehabilitation vs. surveillance. 
Almost by definition, drug courts are more than minimally 
rehabilitative; our rankings reflect this.  Programs that stated that 
they considered themselves strongly rehabilitative were ranked as 
"high." Those programs that considered themselves a mixture of "the 
carrot and the stick"  were classified as "moderate." Four programs were 
classified as "high,"  10 as "moderate."  In many of the programs, the 
degree of rehabilitative focus varied by role.  Not unexpectedly, the 
district or state's attorney was often the team member most interested 
in public safety issues--and  the least "rehabilitative"  in focus. 
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In summary,  we ranked the participating sites in a preliminary 
fashion  based on information available.  Table 6.2 presents the 
rankings.  We ranked pure "post-plea''  programs as having the highest 
leverage;  programs that were mixed were ranked as moderate.  Population 
severity was generally considered moderate,  given that violent offenders 
and those with severe mental health issues were excluded.  Intensity was 
determined based on the length and intensity'of  treatment,  urinalysis 
requirements,  and appearances before the court (generally  using the 
first phase of treatment).  Predictability,  was ranked minimum for a 
number of courts based on observations that sanctions  were often not 
applied consistently and were made often on a case-by-cases  basis. 
Finally,  rehabilitation focus was determined based on comments and', 
discussions  made during our site visits on the extent to whiclh court 
members saw their court as surveillance- vs. rehabilitation-oriented. 
\ 
\ 
I 
Table 6.2 
Typology of  14 Participating Drug Court Programs 
Popul  a  ti  on  Predict  -  Rehabil  i  - 
Site  Leverage  Severity  Intensity  ability  tation 
At  1  ant  a  moderate  moderate  high  moderate  moderate 
Birmingham  high  moderate  moderate  moderate  moderate 
Brook  1  yn  high  moderate  high  moderate  high 
Chicago  high  minimum  minimum  moderate  high 
Kankakee  high  mod  era  t  e  moderate  moderate  moderate 
Omaha  high  moderate  moderate  minimum  high 
Riverside  moderate  moderate  high  high  moderate 
Roanoke  high  moderate  high  minimum  moderate 
Sacramento  high  moderate  moderate  high  high 
San Juan  moderate  moderate  moderate  minimum  moderate 
Santa Barbara  high  moderate  high  minimum  moderate 
Spokane  minimum  moderate  moderate  minimum  moderate 
Tampa  minimum  minimum  moderate  minimum  moderate 
Tuscaloosa  moderate  moderate  moderate  high  moderate 
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VII.  PROGRAM EVALUABILITY 
ASSESSING EVALUABILITY OF THE 14 DRUG COURTS 
The third research task for our evaluation was to assess the 
"evaluability"  of each of the 14 courts €or an outcome evaluation. 
Evaluability would then help researchers design the strongest possible study 
design for each program in a second phase of research. 
Our analysis of the evaluability of each of the 14 sites  was based upon 
inf'ormation  gathered from site visits made to each program by study staff, 
including program documents and manuals; interviews with Drug Court staff, 
judges,  prosecutors, defense attorneys,  and treatment providers; examination 
of paper and computerized records; and observation of drug court proceedings. 
In general we found that the strongest design for most sites,  given their 
current data collection activities,  would be quasi-experimental and limited to 
administrative data, and would require a fair amount of on-site  abstraction. 
Table 7.1 summarizes key infdrmation relevant for program evaluability.  a 
This document is a research report submitted to the U.S. Department of Justice. This report has
not been published by the Department. Opinions or points of view expressed are those of the
author(s) and do not necessarily reflect the official position or policies of the U.S. Department of
Justice.-  62 - 
Table 7.1 
Drug Court Evaluability Questions 
Statistics on 
Current  Compl  et  i  ons/  Services  Completion  DCPO 
Site  Evaluation  Outcomes Being Used  Terminations  MIS System  Received  Rates  El  emen  t  s 
Attendance at 
treatment  Yes 
Number of graduates  ~ 
At  Ian  t  a  None  UA results  Yes  (marginal)  Yes  Yes  Most 
- 
In  6-month follow-up  on 
Process/  Graduation from 
Birmingham  progress  treatment  Yes  Yes  Yes  No  Some 
Brook  1  yn  Impact  treatment  ?e  s  Yes  Yes  Yes  Yes 
Number of clients 
Number of grads 
Chicago  None  Recidivism rates  Yes  None  No  No  No 
Kankakee  Process  no recidivism  Yes  (marginal)  Yes  Yes  Most 
Omaha  Process  Recidivism  Yes  Yes  No  No  Yes 
Outcomes/  Grads: drug-free  and  Yes 
Out  comes  / 
Graduation 
GED  Yes 
Riverside  Outcomes  Abstinence  Yes  (marginal)  Unknown  Yes  Unknown 
Roanoke  Process  months  Yes  No  No  No  No 
Sac  ramen  t  o  Process  Graduation rate  Yes  (marginal)  No  No 
No positive UA for 6 
Yes 
Unknown 
:  None, but 
Graduaticn from  implement- 
San Juan  Process  treatment  Yes  ing one  No  No  No 
(continued  on next page) 
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Table 7.1  (cont’d) 
Drug Court Evaluability Questions 
Statistics on 
Current  Completions/  Services  Completion  DCPO 
Site  Evaluation  Outcomes Being Used  Terminations  MIS System  Received  Rates  Elements 
Graduation 
Recidivism at 12  Yes 
Santa Barbara  Outcomes  months  Yes  (marginal  )  No  No  Some 
Spokane  Outcomes  Avoided sentences  Yes  Yes  Yes  Yes  Yes 
Process/  Recidivism 
None, but 
Gross process  implement- 
No re-arrest on new 
charge 
Tampa  Process  Case flow  Yes  ing one  No  No  Some 
Tuscaloosa  None  Program completion  Yes  None  No  No  Some 
(continued  on next page) 
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Table 7.1  (cont'd) 
Drug Court Evaluability Questions 
Random  When  Is DC 
Assignment  Best  Comparison  Data for 
Possible  ?  Groups  Comparison  Group  End?  of Site Visit 
Scheduled  to  DC  Clients at Time 
Site 
Atlanta  No  None  N/A  Unclear  106 
Birmingham  circumstance  sentencing program  Unknown  Unclear  380 
Depends on  Drug-deferred 
Offenders in other 
Brook  1  yn 
Drug School people  When DCPO 
People who are not  Data from nearby  funding ends: 
Brook  1  yn  No  prosecution zones  CJS data  Unclear  497 
Chicago  No  eligible  police districts  9/99  77 
When DCPO 
funding ends: 
Kankakee  No  TASC  TASC data  12/31/99  60  (capacity) 
Probat  ion  DCPO funding 
First offenders on  CJ records  through 
PClOOO 
Probat  ion 
DRC 
Probat  ion 
except for no  IOP with more  DRC 
Yes, if same  PClOOO 
Omaha  Uncertain  probat  ion  ineligible cases  5/31/2000  300 
Rivers  i  de  No  Prison diversion  Probation  Unclear  53 
Probably,  IOP 
Roanoke  treatment  intense services  Probat  ion  Unclear  85 
Sacramento  out  come  Probation  Probation  Unclear  -  150 
San Juan  No  comparison  Treatment data  OJP 9/30/99  150 
Historical  CJ system 
f 
(continued  on next page) 
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Table 7.1  (cont'd) 
Drug Court Evaluability Questions 
Random  When  Is DC 
Assignment  Best Comparison  Data  for 
Yes,  under  Probation DC 
certain 
No, too few  Recidivism data  CTED Award  ~ 
Scheduled  to  DC  Clients at Time 
Site  Possible?  Groups  Comparison Group  End?  of Site Visit 
PClOOO  87  (South) 
Santa Barbara  circumstances  Short wait list  Unknown  Unclear  121 (North) 
Spokane  cases  " opt  -0u  t  s  "  costs  6/30/2000  103 
Qualified group who 
chooses not to 
Burglary (clients 
similar to DC) 
Tampa  Unclear  enter DC  Re-&idivism  data  Unclear  160 (capacity) 
Tuscaloosa  Yes  Diversion programs  Unknown  Unclear  300  (capacity) 
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DCPO  Guidelines For  Drug Court  Programs 
Ideally, each drug court would have been able to meet the 
requirements of process and outcome collection specified in the DCPO 
“Program  Guidelines and Application Information.” These include the 
collection of information on drug court participants (and  to the fullest 
possible extent, non-participants),  including demographic 
characteristics; substance abuse history;  vocational and educational 
status;  mental health history; criminal justice history; treatment 
needs,  etc.; measures of program implementation and process, including 
program intervention  received,  participation in treatment,  motivation, 
and actual attendance records for each program component; status at 
completion of drug court; service needs at discharge from program; etc. 
Programs were strongly urged to design, implement,  and maintain an 
automated database for recording these variables. 
In addition,  programs were alerted to the requirements of a 
national evaluation.  Drug court programs were instructed to anticipate 
providing the following additional information for a national evaluator: 
substance abuse treatment and support services completion rates, 
counselor ratings of  extent of participant attendance and engagement in 
treatment,  program components and improvement over time in life skills 
acquisition,  psychological and emotional functioning,  educational and 
employment status,  participant satisfaction with the treatment program, 
reports of  substance abuse, results of urinalysis, date and nature of 
violations and arrests, positive social adjustment,  and engagement in 
aftercare components and referrals services following completion of the 
drug court program 
Our site visits and analyses revealed that none of the 14 programs 
had gathered the full range of measures specified by DCPO into a single 
database for both the drug court and a comparison group of offenders. 
This is not to say that sites were uninterested in gathering information 
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or in evaluation or their drug courts.  On the contrary,  all were keenly 
interested in determining whether or not their programs were effective. 
However, it appeared that a great deal of staff time was devoted to the 
day-to-day  operations, coordination among agencies,  provision of 
services,  etc., leaving little time for staff to develop database 
systems and record a vast array of measures for participants. 
Looking across programs,  we found that in several sites,  no local 
evaluation of the program had been conducted.  In half the sites, no MIS 
recorded the required data elements;  records were maintained only on 
paper.  Nonetheless,  our discussions with local drug court staff and 
other criminal justice actors identified potential comparison groups 
that might be used for quasi-experimental designs in most of the sites; 
a few might be able to participate in randomized experiments.  The 
possibility of random assignment appears infrequent due to two major 
considerations.  Unless programs obtain additional funding,  many may not 
be in operation (thus  we qnnot conduct a prospective study).  In 
addition,  many programs are able to handle all available clients, 
providing little incentive for sites to "deny"  the drug court  (and 
assign the person to a control group) to any eligible offender. 
Possible Research Designs 
In terms of classic process and outcomes studies,  most sites could 
offer the following types of data using quasi-experimental evaluation 
designs  - 
Background characteristics.  Often computerized,  sometimes paper 
and pencil screening and/or treatment files, could provide these 
characteristics for drug court participants; generally, less complete 
paper and pencil data would be available for comparison groups. 
Process data.  Urinalysis results are generally available and 
often computerized (particularly  if TASC  was part of the team); services 
received have been computerized in about half the sites.  In many sites, 
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detailed information about treatment participation and activities would 
need to be gathered from individual treatment program files--not  , 
necessarily kept by the drug court itself. 
For process measures, virtually all information currently 
available is official record; no data on participants' self-reported 
satisfaction,  peryeptions, or other behaviors are available; information 
on counselor perceptions is also not availabie. 
reported process variables would need to be collected by the national 
evaluator--they  are  not being collected by the sites.  These measures 
are necessary for testing theoretical hypotheses about why the drug 
courts may be effective.  Without them,  we cannot tell why the drug 
court did or did not produce the effects it desired. 
In general self- 
Outcome,data. All sites are able to report the termination status 
of drug court participants, although this was not automated at all 
sites.  The most frequently used outcomes are officially-recorded 
recidivism,  gathered from,criminal history databases or probation files. 
Remaining drug free,  as measured by negative urine tests, is another 
commonly used outcome measure.  Referral to and completion of programs 
after drug court termination are not available. 
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VIII.  SUMMARY  AND CONCLUSIONS 
The Drug Courts Program Office (DCPO)  provides funding to drug 
courts for planning, implementation, and enhancement of local drug 
courts.  In 1995 and 1996,  14 programs received DCPO implementation, 
grant funding.  These sites were asked to cooperate with a national 
evaluation funded by the National Institute of Justice (NIJ). This 
report presents fi'ndings  on 
program implementation of the drug courts 
a conceptual framework of the 14 drug courts funded by DCPO 
program evaluability for participating jurisdictions12  I, 
4 
We summarize the findings of each of the major tasks, then discuss 
evaluation issues within a broader context. 
PROGRAM IMPLEMENTATION  ' 
Our analysis of program implementation--the  types of models 
implemented,  eligibility requirements,  court and treatment requirements, 
and program implementation difficulties--reads  surprising like findings 
from the surveys conducted by American University and National TASC. 
These 14 programs are in many ways typical of drug court programs across 
the county. 
To a large degree, the 14 programs meet many of the key components 
of effective  drug court programs.  Drug courts integrate alcohol and 
other drug treatment services with justice system case processing; they 
use a non-adversarial approach;  prosecution and defense counsel promote 
public safety while protecting due process rights of participants; 
l2 Additionally, the project was to propose a Phase I1 evaluation 
plan for each of the 14 sites.  Our determination was that most sites 
could support only limited process and outcomes studies,  and that an 
alternate methodology be employed.  Details of this approach can be 
obtained from the authors. 
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eligible offenders  are identified early; drug courts provide access to a 
continuum of alcohol,  drug, and other treatment related services; 
abstinence is monitored by frequent testing; a coordinated strategy 
governs drug court responses to participants' compliance; and ongoing 
judicial interaction  with each participant is maintained. 
that the most difficult  component to meet was the monitoring and 
evaluation for the achievement of program goals and effectiveness.  In 
the 14 sites we examined, this clearly was not implemented to the degree 
of other key elements. 
It,appeared 
However, even with the other nine key elements, the 14 sites 
experienced success in varying degrees.  Access to a continuum of 
alcohol and drug services and other related rehabilitative services was 
often difficult, reflecting funding issues, as well as close 
coordination and information flow issues between treatment providers and 
other drug court staff.  Although drug courts may specify  protocols and 
graduated sanctions for nqn-compliance,  in some instances a more 
individually tailored response is used. 
CONCEPTUAL FRAMEWORK 
Our framework was developed to define structure and pr.ocess  in 
ways that are measurable and amenable to hypothesis testing.  The 
framework has five dimensions: leverage,  population severity, intensity, 
predictability,  and rehabilitation emphasis.  The first two dimensions 
are structural characteristics of drug court.  Leverage refers to the 
nature of consequences faced by incoming participants if they later fail 
to meet program requirements and are discharged from drug court. 
Population severity refers to characteristics of offenders deemed 
eligible to enter drug court.  The other three dimensions are process 
characteristics.  They describe what happens to participants as they 
proceed through the drug court program.  Intensity refers to 
requirements for  participating in and completing drug court.  These 
always include urine testing,  court appearances,  and drug abuse 
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treatment.  Predictability  reflects the degree to which participants 
know how the court will respond if they are compliant or noncompliant. 
Courts with'  less variability in responses to each positive test are more 
predictable; participants are more likely to know what will probably 
happen to them if they test positive once, twice, and so on. The final 
dimension in our framework is the emphasis placed on rehabilitation as 
against other court functions, including case'  processing and punishment. 
Other things being equal, we would expect more positive drug court 
outcomes for drug courts that rank high on'indicators  of intensity,  I 
predictability, rehabilitation,  and leverage.  The effect of population 
severity on outcomes most likely depends upon other dimensions of the 
framework;  thus we made no simple hypotheses for this component., 
provide examples of these dimensions using the 14 drug caurts'! Our 
assessment of the dimensions is tentative,  however, since we were not 
able to gather the data we suggest is needed to fully document each 
dimension.  Our analysis 3hows variation across sites that might be 
useful for future analyses of program outcomes. 
We 
"EVALUABILITY" OF THE 14 DRUG COURT PROGRAMS 
Our analysis of the "evaluability"  of each of the 14 sites was 
based upon information gathered from site visits made to each program by 
study staff that included program documents and manuals; interviews  with 
Drug Court staff, judges,  prosecutors, defense attorneys,  and treatment 
providers; examination of paper and computerized records;  and 
observation of drug court proceedings.  In general,  we found that the 
strongest design for most sites,  given their current data collection 
activities, would be quasi-experimental and limited to administrative 
data, and would require a fair amount of on-site  abstraction.  Many 
sites did not routinely collect the data items recommended by the DCPO. 
The greatest stumbling blocks to traditional evaluation were the 
lack of integrated management information system and adeqiate comparison 
groups.  In addition, self-reported information on offender and system 
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actor perceptions, necessary for understanding the "black  box" of drug 
court treatment,  were not collected by sites. 
TAKING DRUG COURT RESEARCH  A  STEP FURTHER 
Drug court research is at a crossroads.  Available information  to 
date suggests that programs deliver more intensive services  with 
positive outcomes for recidivism and'  drug use',  at least in the short 
term.  However,  many of these results come from weak evaluation designs. 
Conducting additional weak evaluafions may,add  little to our knowledge. 
Recently, researchers and observers in the field have been calling for 
more sophisticated research into testing the theory behind how drug 
courts achieve their results (Harrell  19991, evaluating the treatment 
component using principals of effective intervention (Johnson,  Hubbard, 
and Latessa 2000),  untangling the drug court "package"  to determine 
which components  make a difference (Belenko  2000,  Marlowe and Festinger 
2000;  Goldkamp,  White, and-  Robinson 2000),  and conducting cost-benefit 
analyses in a rigorous manner (California  Judicial Council 2000).  For 
example, the National Institute on Drug Abuse has recently funded a set 
of program evaluations to answer questions about specific components of 
drug court programs.  Projects currently underway include a clinical 
trial of Multi Systemic Therapy for juveniles, the use of vouchers in 
drug courts, and a randomized design that varies the nature of judicial 
hearings in five jurisdictions.  Johnson,  Hubbard, and Latessa (2000) 
argue that many treatment programs utilized by drug court programs may 
not be delivering the best treatment to clients.  They suggest more 
attention  be paid to the type and quality of  treatment services, 
including the dpplication of the principles of effective intervention. 
Central to any future evaluations,  however, is the development at 
! 
I 
each site of a management information system (MIS)  that capture the 
required background,  process, and outcome measures important to all 
research designs.  Our study of the 14 drug court programs revealed that 
many did not have an MIS in place, despite the availability of several 
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(e.g.,  Jacksonville and Buffalo Drug Court MIS, Washington/Baltimore 
High Intensity Drug Trafficking Area  (HIDTA)  Treatment Tracking System). 
It may be that the available systems do not provide full-service drug 
court management information  capability (Mahoney  et al. 19981, or the 
difficulties involved in establishing systems (e.g.,  costs,  coordinating 
agencies) may be too great for many jurisdictions,  particularly smaller 
ones. 
In addition to providing useful information on process and outcome 
measures, comprehensive  MISS have implications for the timeliness of 
client information-sharing  and thus for clients' access to services. 
Linkages can be more readily made, and referrals  more prompt and 
appropriate, if the drug court's MIS includes data on a full array of 
client needs and if the assessment tools are suitably rigorous. 
The importance of drug court evaluation cannot be overstated.  The 
drug court model has been adopted in a variety of other areas, including 
mental health, domestic vijolence,  and DUI sentencing.  It is imperative 
that we gain a better understanding of overall impact, theoretical 
underpinnings,  and key components if the drug court model is to be 
widely disseminated as a successful approach for treating a variety of 
criminal behaviors and associated illnesses. 
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APPENDIX 
SITE VISIT PROTOCOL 
This document is a research report submitted to the U.S. Department of Justice. This report has
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Justice.DRUG COURT EVALUATION 
SITE VISIT PROTOCOL 
NAME OF PROGRAM:  START DATE 
Note: The Protocol is not intended as a strict structured interview, and you are not required 
to ask each question verbatim.  Likewise, the check marks on the Protocol indicating the 
prospective respondents to each question are suggestions rather than mandates. 
Proeram model 
1. At what point(s) in the criminal justice process does the drug 
court obtain its clients? 
General Program Characteristics 
2.  How does this program compare (in terms of clients targeted, 
services offered) with other programs the jurisdiction offers for drug- 
offending clients (i.e., What is business as usual?, TASC?) 
3.  What are the stages or phases of intervention?  (How long do they 
last?) 
4. Are protocols formalized? (If yes, can we get a copy?) 
5. Who is called to appear in a drug court session (new admits, 
progress reporters, failures), and what is the order of  appearance? 
6. Is there a plan or set of guidelines for internal monitoring of drug 
court program quality?  (Probe: Are performance indicators 
monitored?) 
Client eligibility, flow, and characteristics 
7.  What are the eligibility requirements (and exclusion criteria) for 
participation?  How were these criteria decided upon? 
8.  By whom are offenders referred to the drug court? 
~~  ~  ~~~~ 
9.  How are the offenders screened for eligibility (e.g., What tools 
are used?  Who performs the screening?) 
Drug Court Evaluation Site Visit Protocol - rebised 5/21/99 
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10. What percentage of drug-involved offenders in this jurisdiction 
are eligible for the drug court? 
11. What percentage of  drug-involved offenders referred to this drug 
court end up in the program? 
12. How many participants can the program handle at one time? 
(What is the capacity of the program?) 
13. What is the average length of time a participant spends in the drug 
court program? 
14. What are the characteristics of the drug court's participants? (e.g., 
What are the drugs most commonly used by offenders entering the 
drug court program?, What are the primary drugs of abuse?) 
Items recommended by DCPO to collect: 
Demographic characteristics 
AOD history and current use 
AOD treatment history 
Family relationships and social functioning 
Vocational status 
Economic status 
Academic achievement 
Mental health history (including physical and sexual abuse) 
Medical history (including HIV risk behaviors) 
CJ history (crime type, prior record) 
Attitudes toward treatment, motivation/readiness 
Initial treatment and support service needs 
Program interventions received 
Participation in treatment (e.g., attendance) 
Program admission and discharge date 
DC program completion status (e.g., successful) (outcome) 
CJ status at discharge (e.g., probation) (outcome) 
Service needs at discharge 
Discharge referrals initiated by DC 
15. How many different people (and in what positions) make up the 
staff that operate the drug court? 
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Environmentlcontext 
16. Are there any policies or laws that affect availability of offenders 
for diversion through drug courts? 
17. Has the drug court program been affected by local treatment or 
services capacity, local treatment quality, community support for 
treatment, local detention capacity, the mix of  defendants (current 
charges, criminal and drug-use histones), or local drug use 
epidemiology?  I 
18. For this fiscal year, what are the different sources of funding for 
the operation of the drug court (not including treatment and other 
services), and what proportion of the total funding comes frdm each 
source?  (Try to obtain budget document). 
__  ~  ~__ 
Funding and costs 
19. What are the funding sources for the substance abuse treatment 
and other services the client receives while in the drug court (e.g., 
third party payment systems, reliance on grants, philanthropists, 
nontraditional partners, entitlement and insurance income)? 
(Probe: Be sure to ask about volunteers, in-kind contributions, 
etc.) 
20. Are enough funds available to purchase necessary treatment and 
other services?  What short falls, if any, exist? 
21. What are the disaggregated costs of drug testing, supervision, 
detention, treatment, and other services?  Can you give me a budget 
that shows how you break out costs in your reports? Are per client 
costs available? 
Provision of treatment and other services 
22. What screening and assessment tools are used to determine the 
seventy of  drug or alcohol problems and treatment placement?  Who 
performs the assessment? 
23. For what other service needs are offenders screened or assessed 
(e.g., infectious diseases, illness, literacy, victimization history, 
education)? What tools are used?  Who performs the screening and 
assessment  ? 
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24. What is the type of substance abuse treatment that is offered? 
(Probe: Find out what treatment consists of (e.g., What are the 
types of providers?  How many hours per day/ days per week are 
spent in treatment?  Is the treatment approach different than 
usual? What are the credentials of the people on staff?) 
25. How is a case handled from the time a client enters the drug court 
program to the time he/she leaves or is discharged? With whom does 
the responsibility for the client lie? 
26. What are the data that the judge uses to review a client’s 
progress? 
Reinforcements/Punishments /  RewarddSanctions 
27. What are the rewards, and do they vary by action? 
28. What are the sanctions, and do they vary by action? 
29. Who decides when and which sanctions and rewards are used? 
30. What are the time lags between violation or noncompliance and 
detection and consequence? 
31. How are the expectations for the offender communicated to 
hirdher? 
32. Are graduated sanctions implemented consistently over time and 
across offenders, or is there a great deal of consideration given to the 
individual circumstances of the noncompliance event? How 
specifically does your program define graduated sanctions? 
33. What is the magnitude of the behavioral demands placed on 
offenders (e.g., How many hours per week are required to perform 
court requirements?  How much does it cost the offender financially, 
etc.?)? 
34. How realistic/attainable are the behavioral requirements placed on 
court participants (i.e., Do they require behaviors that are within the 
offenders current behavioral repertoire, or do they really require the 
offender to stretch to meet program expectations)? 
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In tensity 
35. On average, how many times during the program does a 
successful client have contact with: 
-  Judge 
- 
-  Treatment providers 
-  Other service providers 
-  Probation 
Other officers of the court 
36. On average, how many times during the program does a 
unsuccessful client have contact with: 
Other officers of the court 
-  Judge 
- 
-  Treatment providers 
-  Other service providers 
-  Probation 
.  ~~ 
Philosophy: rehabilitation vs. surveillance 
37. What is the program's philosophy about the rehabilitation vs. 
surveillance function of  a drug court?  (Obtain both perspectives: 
What does the program think?  What do site visitors think?) 
38. What proportion of  offenders is placed in substance abuse 
treatment? 
39. What proportion of  offenders receives social or health services 
other than substance abuse treatment, among clients who need other 
services? 
Monitoring and supervision 
40. How often are offenders tested for drugs and alcohol?  What tests 
are used?  On what schedule are offenders tested? Who does the 
testing?  How do testing results come back to the judge? 
Linkage and collaboration 
41. What is the nature of the collaboration with pretrial services, 
probation, parole, treatment providers, other social service or health 
care providers (e.g., medical and mental health) and community 
agencies?  (Are they formal, e.g., through contracts or signed 
agreements, or informal?) 
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42. Do the drug court staff and collaborating agencies know when 
programmatic changes occur in the drug court? How are the agencies 
kept apprised? 
43. Are people and agencies involved with serving the client getting 
the information they need about the client?  Is there information 
about the client they are not getting? 
44. Is the system set up in a day  that serves all of the agencies well?  1 
If  not, what should be changed? 
45. Is there an operational management information system, one that 
allows for rapid retrieval and exchange of infomation about clients 
among existing Criminal Justice, public, health, and qocial service 
agency systems? If  not, are they in the process of developing one or 
do they have concrete plans for one? 
Administrative leadership and cooperation 
46. Do you belong to the National Association of Drug Court 
Professionals? 
~  ~____ 
47. Have you presented information about your drug court to peers or 
other audiences?  Which ones? 
48. How often is your program visited? 
49. How involved is the judge in making treatment determinations, 
vs. leaving that decision up to the treatment providers? 
50. Who is responsible for coordination among agencies? 
Management of information? Case management?  Monitoring of the 
program?  Determining success of clients? Program reviews? 
Recommending modifications? 
51. How are decisions made about the drug court program? 
52. How receptive is the judge to the opinions and input of the 
providers and other members of the drug court staff? 
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Program implementation 
53. To what extent does the program as implemented conform to the 
program model and planned procedures?  How did procedures change 
over time (e.g., change in drug test procedures to cut cost or take 
advantage of new test technologies)?  Why did you decide to run 
your program as you are now doing?  How have things played 
out? 
Implementation Barriers  '  I 
54. What aspects of the program were most difficult to implement and 
why? 
55. What bottlenecks, resource problems, program adaptation's, 
organizational characteristics, or other factors facilitated or impeded 
implementation? 
56. What issues still need to be resolved, in your opinion? 
57. Basecton your experiences, what advice would you give to other 
jurisdictions and drug courts considering implementation? 
Evalua  bili ty 
58. Are there evaluations ongoing? What have they found? (Try and 
obtain copies of any evaluations.) 
59. What measures of client outcome and program effectiveness is 
the program using currently? 
60. How is success defined for an offender in this program?  What is 
an effective program? 
61. Does the program keep statistics on program completions and 
tenninati ons  ? 
~~ 
62. Are cost of services data and other record-of-service data 
available at the client-level and for all points of service contact in the 
program?  What is the quality of these data (e.g, routinely gathered? 
complete? accurately reported and entered?)  By what method are the 
data collected and recorded? 
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63. What information is available for us to follow and assess a client 
(whether a “success” or “failure”) one year after discharge? 5 years 
after discharge? 
64. To what extent does the program have the staffing and resource 
infrastructure (e.g., MIS) to support additional data collection efforts? 
65. Would the program be willing to use additional or different 
instruments to screen or assess clients? 
66. Does the program understand that additional data collection 
involves some additional complexity and burden for the system? 
67. How feasible would it be to access and utilize client medical, 
clinic, and criminal justice records in this jurisdiction and locality? 
68. How willing would the program be to allow assignment of 
eligible offenders to different kinds of treatment or services within 
the program, or to judicial interventions other than the drug court 
program? 
69. Where might reasonable comparison groups be found?  What is 
the size of this group? What types of data are available for this 
group? 
70. What stakeholders would need to be involved at this site during 
planning and implementation of  an outcome evaluation‘? 
71. May we contact you for additional information? 
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